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The use of ozone-biofiltration (BAF) for water reuse has recently been viewed as an attractive 
option due its low cost and ability to achieve high quality effluent. However, one challenge that 
is particularly problematic for ozone-biofiltration is the occurrence of trace organic compounds 
(TOrCs), such as pharmaceuticals and personal care products, in domestic wastewater, 
primarily due to their uncertain public health impacts. These TOrCs might be degraded by three 
ammonia oxidizing microorganisms (AOMs), including ammonia oxidizing bacteria (AOBs), 
ammonia oxidizing archaea (AOAs), and Comammox that have been found in biofiltration 
systems. Cometabolism, the fortuitous biodegradation of compounds by enzymes used for 
primary metabolism, allow AOMs to biodegrade some TOrCs, but the extent of degradation is 
dependent on chemical structure and composition of the microbial community.  
The goal of this thesis research was to determine the role of AOMs in degrading TOrCs in 
wastewater reuse biofilters, primarily focusing on acetaminophen, caffeine, ibuprofen, and 
naproxen. The research focused on investigating TOrC biodegradation by evaluating three pilot 
biofiltration columns: 1) a control column, fed only secondary effluent, 2) a column fed 
secondary effluent with 2 mg N/L additional ammonia, and 3) a column fed secondary effluent 
with 0.3 mg/L of monochloramine. Each column contained 10-year old biological activated 
carbon media and was operated with a 10 min empty bed contact time.  The control BAF served 
as a baseline and displayed extremely limited nitrification and no denitrification. The ammonia 
dosed BAF exhibited nitrification and very limited denitrification. The chloramine dosed BAF 
exhibited extremely limited nitrification and denitrification. The chloramine dosed column 
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outperformed the control in the reduction of ibuprofen and naproxen. Additionally, the 
chloramine dosed column outperformed the ammonia column in degradation of nearly all 
TOrCs. The addition of ammonia was surprisingly significantly worse in TOrC reduction than the 
control for all TOrCs that were analyzed. For biological analysis, it was assumed that the 
biomass was consistent across all three columns given that the effluent adenosine triphosphate 
levels were consistent throughout the study. Therefore, the AOM community assay results 
were normalized by the 16S rRNA gene assay results to provide relative abundances that are 
suitable for comparison. The AOM community in the ammonia dosed BAF was dominated by 
AOBs, unlike those in the control and chloramine dosed BAFs, which were dominated by 
Comammox. Interestingly, the chloramine dosed BAF displayed the highest overall relative 
abundance of AOMs in the top and bottom depths. The results of this study suggest that it is 
not AOB, but Comammox that may be responsible for effective TOrC reduction and the 
presence of excess ammonia into a BAF system is not beneficial for TOrC attenuation. However, 
the addition of a low dose of monochloramine in BAF systems can be beneficial for AOM 
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Chapter 1: Introduction 
1.1 Background 
The decline of reliable drinking water supplies is a growing issue as many regions face drought, 
population growth and a diminishing supply of clean groundwater and surface water resources. 
As a result, some engineers, scientists, and policy makers have turned to indirect potable reuse 
(IPR) as a means to augment surface and groundwater resources. Another approach to meet 
these demands involves potable water reuse directly from an advanced water purification 
facility—also known as direct potable reuse (DPR). To meet the evolving demands and 
increased popularity of potable reuse, the California Division of Drinking Water (CA DDW) has 
established regulatory frameworks for a potable reuse policy. In many instances, the California 
regulations require full advanced treatment (FAT) consisting of reverse osmosis (RO) and an 
advanced oxidation process (AOP) (CDPH, 2014). While this treatment train has proven 
effective in the context of public health, there are concerns about its sustainability (Gerrity et 
al., 2014), especially for inland regions where brine disposal is an issue. One promising 
alternative is a treatment train employing ozone-biofiltration (Gerrity et al., 2013), which has 
been shown to provide similar treatment efficacy for some treatment objectives (Amoueyan et 
al., 2017; Trussell et al., 2016). An ozone-biofiltration-based treatment train may be a more 
appropriate alternative for potable reuse treatment in areas where FAT is not mandated.  
The occurrence of trace organic compounds (TOrCs) such as pharmaceuticals and personal care 
products (PPCPs) in domestic wastewater is an increasing area of study due to the uncertain 
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public health impacts of complex TOrC mixtures, the potential for endocrine disruption and 
other adverse impacts to wildlife and the environment (Lee et al., 2012), and even the 
proliferation of antimicrobial resistance (Yang et al., 2011). With increased interest in potable 
reuse, there is a need to better characterize TOrC attenuation by advanced treatment, 
specifically with ozone-biofiltration. Ozone has been proven effective in degrading TOrCs via 
oxidation (Snyder et al., 2006). Bacterial communities in biofiltration alone have the capacity to  
effectively degrade naturally occurring taste and odor causing compounds, oxidation by-
products, and inorganic compounds such as ammonium/ammonia by converting them to nitrite 
and nitrate; while TOrC removal varies by compound (Brown et al., 2015, 2018; Greenstein et 
al., 2018).  
Cometabolism (secondary substrate utilization), the fortuitous biodegradation of compounds 
by enzymes used for primary substrate metabolism, allows bacterial communities to remove 
some TOrCs, but removal is dependent on chemical structure and the composition of the 
microbial community (Zearley & Summers, 2012). Many studies have been conducted to 
characterize TOrC removal by biofiltration (Greenstein et al., 2018; Hallé et al., 2015; Rattier et 
al., 2014; Zearley & Summers, 2012; Zhang et al., 2017), but these studies have reached 
conflicting conclusions on the performance of biofiltration degrading certain TOrCs. Although 
Water Research Foundation Report 4559 (Dickenson et al., 2018) has reported adverse impacts 
to performance when using prechloramination with biofiltration such as no manganese 
removal and incomplete nitrification, little research has been conducted on TOrC removal using 
prechloramination with biofiltration with respect to water reuse. 
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 The two traditional ammonia oxidizing microorganisms (AOMs) include ammonia 
oxidizing bacteria (AOBs) and ammonia oxidizing archaea (AOAs). Both AOBs and AOAs are 
found in wastewater biotrickling filter systems as well as drinking water treatment and 
distribution systems although it is unclear which group dominates (Roy et al., 2017, 2020). 
Recent studies have shown the presence of complete ammonia oxidizers (Comammox), a third 
group of AOMs, in full-scale wastewater treatment plants (WWTPs) (Roots et al., 2019; M. 
Wang et al., 2018) and in drinking water (Wang et al., 2017). Unlike AOBs and AOAs, 
Comammox convert not only ammonia into nitrite but also nitrite into nitrate, which is the 
second step of nitrification previously thought to be completed by nitrite oxidizing bacteria 
(NOB) alone.  Biotrickling filter colonization by AOBs and AOAs depends on temperature and 
ammonia availability; AOB abundance increases with ammonia concentration while it is the 
opposite for AOA abundance (Roy et al., 2017).  
 
1.2 Research Justification and Problem Statement 
Studies suggested that biotransformation or biodegradation of TOrCs is linked to nitrifying 
activity in drinking water biofilters (Greenstein et al., 2018; Rattier et al., 2014). The presence of 
nitrification inhibitor allylthiourea (ATU) reduced dissolved oxygen (DO) consumption, and 
decreased removal of dissolved organic carbon (DOC), and several TOrCs (Rattier et al., 2014). 
This is evidence that biodegradation of TOrCs is linked to nitrifying activity. Furthermore, the 
removal of TOrCs coinciding with removal of ammonia in drinking water biofilters was reported 
by Greenstein et al. (2018). Therefore, systems with higher levels of nitrification or nitrification 
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potential may be better adapted for TOrC attenuation. While these two studies suggested a 
correlation between ammonia oxidation and TOrC degradation, causation was not determined 
and the development of AOMs was not investigated. This study aims to go deeper by promoting 
AOB and AOA development in biofilters by spiking ammonia or chloramines and quantifying 
concurrent changes in TOrC attenuation to provide concrete evidence of cometabolism by AOM 
populations. TOrC attenuation will be based on indicator compounds and changes in microbial 
community structure, specifically the abundance of AOBs, AOAs, and Comammox bacteria. 
These microorganisms will be quantified using quantitative polymerase chain reaction (qPCR) 
targeting taxa-specific ammonia monooxygenase (amoA) genes linked to nitrification/TOrC 
degradation. The ammonia monooxygenase (AMO) enzymes encoded by amoA genes have 
already been shown to co-metabolize various hydrocarbons (Shi et al., 2004) and even more 
complex chemical compounds such as 17α-ethinylestradiol (Yi & Harper, 2007). 
 
1.3 Goal, Objectives, and Hypotheses 
The goal of this thesis research is to determine the role of AOMs in degrading TOrCs in 
wastewater reuse biofilters. 
The research has three objectives and associated hypotheses. 
Objective 1 
Investigate the impacts of additional ammonia dosing on degradation of TOrCs. 
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Research question 
Will additional ammonia promote the growth of AOBs in the biofilter that can more effectively 
degrade TOrCs? 
Hypothesis 
Ammonia addition increases the removal of TOrCs due to biodegradation via AOB co-
metabolism. This will be shown by comparing the relative abundance of AOB genes in the 
control and ammonia spiked columns with respective TOrC degradation. 
Rationale for hypothesis 
The addition of ammonia will promote the development of AOBs which are known to have a 
high ammonia affinity (Sonthiphand & Limpiyakorn, 2011). This increase in AOB abundance will 
lead to an increase in AOB cometabolism of TOrCs. 
Objective 2 
Examine the impacts of chloramine dosing on AOMs and the degradation of TOrCs. 
Research question 
What impact will chloramine dosing have on the spatial distributions of AOA and Comammox 
development and therefore activity linked to TOrC degradation in the biofilter? 
Hypothesis 
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While the disinfection activity of chloramines may hinder the community near the inlet, but 
subsequent degradation of chloramines to ammonia as the filter media quenches the residual 
might promote growth of AOAs and Comammox farther down in the column which will lead to 
increased TOrC removal.  
Rationale for hypothesis 
The addition of monochloramine will create a low ammonia environment which favors AOA and 
Comammox development (Roots et al., 2019; Sauder et al., 2012). The increase of AOA and 
Comammox abundance will lead to an increase of AOA and Comammox cometabolism of 
TOrCs. 
Objective 3 
Investigate the abundance of AOB, AOA, and Comammox and their contribution to TOrC 
degradation.  
Research question 
Will AOB, AOA, or Comammox dominate the nitrifying communities of  the control, ammonia 
dosed, and chloramine dosed BAFs, and which will provide the highest degradation of TOrCs? 
Hypothesis 
Comammox will dominate the biofilters and provide the greatest TOrC degradation. 
Rationale for hypothesis 
7 
Research into Comammox dominance is fairly novel; however, a few new studies have found 
Comammox dominance in wastewater treatment plants (Fowler et al., 2018; Roots et al., 2019; 
M. Wang et al., 2018). Comammox also possess the ability to complete the entire nitrification 
process due to their unique AMO enzyme which is thought to cometabolize a wider range of 
TOrCs (Han et al., 2019). 
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Chapter 2: Literature Review 
2.1 Potable Reuse 
The combination of declining reliable surface and groundwater supplies and an increase in 
population is a growing issue particularly in arid regions such as the Southwestern United 
States. These issues along with advancements in treatment and monitoring methods has 
recently led to more sustainable practices such as IPR, for example, augmentation of surface 
and groundwater or DPR where potable water is obtained directly from an advanced water 
purification facility. However, the practice of “de facto reuse” where a city discharges treated 
wastewater into the drinking water supply for downstream cities has been practiced for 
decades. Intentional IPR and DPR systems must utilize multi-barrier treatment approaches and 
must be reliable, robust, redundant, and resilient (Gerrity et al., 2013) to ensure public health 
goals are met. The National Research Council (NRC) published an extensive report in support for 
potable reuse (NRC, 2012) and multiple studies have advocated that finished water from 
advanced treatment plants can meet and often exceed drinking water standards (Amoueyan et 
al., 2017, 2020).  
Intentional IPR has recently gained popularity with a variety of treatment trains consisting of 
conventional wastewater treatment followed by various combinations of advanced treatment 
processes, including granular activated carbon (GAC), biological activated carbon (BAC), 
microfiltration (MF), ultrafiltration (UF), RO, and disinfection with chlorination, ozonation, 
and/or AOP (Gerrity et al., 2013). Only a limited number of DPR projects currently exist, largely 
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due to high costs, public perception, and sustainability concerns. Broad implementation of IPR 
and DPR is also hindered by the limited number of regulatory frameworks currently in place, 
although ongoing efforts by the CA DDW have facilitated efforts in other regions. The CA DDW 
framework requires FAT consisting of RO and AOP for most applications but does provide some 
opportunities for flexibility as long as the overall treatment approach achieves adequate public 
health protection (e.g., log10 reduction values of at least 12, 10, and 10 for viruses, 
Cryptosporidium, and Giardia, respectively) (CDPH, 2014). 
 
2.1.1 Treatment Systems 
The FAT system is considered the “gold standard” for potable reuse treatment trains and has 
proven effective in protecting public health. However, there are concerns about its 
sustainability (Gerrity et al., 2014), especially for inland regions where brine disposal is an issue. 
One promising alternative is a treatment train employing ozone-biofiltration (Gerrity et al., 
2013), which has been shown to provide similar treatment efficacy for some treatment 
objectives (Amoueyan et al., 2017; Trussell et al., 2016). In the future, more potable reuse 
treatment trains will likely be implemented on a case-by-case basis as more experience and 
information are gained. 
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2.1.1.1 Full Advanced Treatment (FAT) 
The FAT train consisting of RO and an AOP—and generally preceded by MF or UF—is able to 
achieve very high-quality effluent. However, high capital, energy, and operation and 
maintenance (O&M) costs, and the need for concentrated brine disposal limit its feasibility, 
particularly for inland areas. As a result, alternative treatment technologies such as ozone 
combined with BAC are becoming increasingly popular. 
 
2.1.1.2 Ozone and Biofiltration Systems 
An ozone-biofiltration-based treatment train may be a more feasible alternative for potable 
reuse treatment in areas where FAT is not mandated because it can provide up to 80% less 
capital costs and 90% less O&M costs than RO based treatment trains such as FAT (Gifford et 
al., 2018). Ozone is a strong oxidant and its reaction with water results in formation of hydroxyl 
radicals (●OH). Both ozone and ●OH are effective in inactivating many pathogens and oxidizing 
bulk/trace organic compounds (Snyder et al., 2006). The formation of ●OH (an even stronger 
oxidant than ozone alone) is crucial as some TOrCs that are ozone resistant (e.g., atrazine and 
meprobamate) can be degraded by ●OH (Gifford et al., 2018). Biofiltration systems use inert 
(i.e., sand, anthracite) or adsorptive (i.e., GAC) media to develop microbial communities. While 
inert media serve only as a filter for bacterial communities to attach, GAC is able to adsorb 
certain compounds including rapid quenching of chlorine and chloramine and host more biofilm 
and microbial activity than inert media (De Vera et al., 2018). These bacterial communities in 
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biofiltration alone have the capacity to  effectively degrade naturally occurring taste and odor 
causing compounds, oxidation by-products, and inorganic compounds such as 
ammonium/ammonia by converting them to nitrite and nitrate; while TOrC removal varies by 
compound (Brown et al., 2015, 2018; Greenstein et al., 2018). In practice, a GAC treatment step 
will typically be used following biofiltration to provide better removal of organics that 
biofiltration alone cannot achieve. 
 
2.2 Trace Organic Compounds 
The discharge of organic compounds (pharmaceuticals, personal care products, steroid 
hormones, surfactants, industrial chemicals, and pesticides) by households, agriculture, and 
industries worldwide into wastewater has created a new challenge for water and wastewater 
professionals. The occurrence of TOrCs in domestic wastewater is an increasing area of study 
due to the uncertain public health impacts of complex TOrC mixtures, the potential for 
endocrine disruption and other adverse impacts to wildlife and the environment (Lee et al., 
2012), and even the proliferation of antimicrobial resistance (Yang et al., 2011). Furthermore, 
conventional treatment methods used by WWTPs are not designed or equipped to eliminate 
recalcitrant TOrCs due to their molecular and/or physio-chemical properties (Grandclément et 
al., 2017).  
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2.2.1 Background and Occurrence 
Extensive research has been conducted on the occurrence of TOrCs in aquatic environments, 
WWTP influent and effluent, groundwater, and seawater. As seen in Table 1, there are five 
main classes of TOrCs that can originate from domestic, agricultural, or industrial sources. A 
comprehensive review of occurrence in drinking water sources was conducted by Benner et al. 
(2013) totaling 17 studies and 130 TOrCs. Reviews of occurrence and fate of TOrCs in 
conventional WWTPs were conducted by several groups (Luo et al., 2014; Margot et al., 2015; 
Onesios et al., 2009). Occurrence of TOrCs varies heavily based on region and season with large 
concentration fluctuations in WWTP influent occurring as often as daily or weekly (Luo et al., 
2014; Margot et al., 2015). In general, the occurrences of pharmaceuticals in sewage, sludge, 
conventional activated sludge, or membrane bioreactor sludge are typically found in 
concentrations ranging from low ng/l to a few µg/l in the liquid phase and a few ng/g to a few 
µg/g in the solid phase in sewage sludge (Grandclément et al., 2017). The widespread 
occurrence can be linked to domestic, agricultural, and industrial sources with WWTPs acting as 
an important barrier against TOrC proliferation even though removal may be unintentional. 
Discharge of TOrCs into the environment can occur from point (i.e. PPCPs) and diffuse sources 
(i.e. pesticides) which may lead to the formation of transformation products that are often 




Table 1: TOrC classification and sources 
TOrC Classes Examples Sources 
Pharmaceuticals  NSAIDs (i.e., ibuprofen, diclofenac), lipid 
regulators (i.e., atorvastatin, 
gemfibrozil), anticonvulsants (i.e., 
carbamazepine, gabapentin), antibiotics 
(i.e., sulfamethoxazole, trimethoprim), 
β-blockers (i.e., atenolol, metoprolol), 
stimulants (i.e., caffeine, nicotine) 





Fragrances (i.e., galaxolide, tonalide), 
disinfectants (i.e., triclosan), insect 
repellents (i.e., DEET) 
Domestic (i.e., bathing, 
shaving, swimming, etc.) 
Steroid Hormones Estrogens (i.e., 17α-ethinylestradiol, 
estradiol) 
Domestic (i.e., excretion), 
agriculture, aquaculture 
Surfactants Soaps, detergents (i.e., Benzalkonium 
chloride, PFOA) 





Plasticizers (i.e., tributyl phosphate), fire 
retardants (i.e., TCEP, TCPP) 
Domestic (i.e., leaching out 
of material) 
Pesticides Insecticides (i.e., diazinon, DDT), 
herbicides (i.e., atrazine, simazine), 
fungicides (i.e., propiconazole, 
tebuconazole) 
Domestic (i.e., gardens, 




2.2.2 TOrC Treatment Processes 
2.2.2.1 Physicochemical Treatment 
Treatment processes that remove TOrCs in conventional WWTPs include sorption to sludge in 
primary treatment (lipophilic compounds), biodegradation/biotransformation, sorption on 
activated sludge, and to a lesser degree volatilization in secondary treatment, while tertiary and 
advanced treatment methods remove TOrCs through a variety of mechanisms (Grandclément 
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et al., 2017; Luo et al., 2014). Sorption to sludge occurs through two mechanisms - absorption, 
where hydrophobic interactions between aliphatic and aromatic groups and the lipophilic cell 
membrane of microorganisms as well as the fat fractions of sludge occur; and adsorption, 
where electrostatic interactions of positively charged groups with negatively charged surfaces 
of the microorganisms and sludge (i.e. amino groups) occur (Luo et al., 2014; Ternes et al., 
2004). Photolysis, membranes, advanced oxidation treatment methods, and adsorption by GAC 
have proven effective in TOrC attenuation (Grandclément et al., 2017; Luo et al., 2014). In 
addition, biological removal of TOrCs is a viable treatment process due its widespread use and 
economic/sustainability benefits. 
 
2.2.2.2 Biodegradation of TOrCs 
Biodegradation of TOrCs can occur through primary substrate utilization by a group of specialist  
oligotrophic organisms (Daughton & Ternes, 1999), co-metabolism (secondary substrate 
utilization) where TOrCs are fortuitously degraded by enzymes (e.g., ammonia monooxygenase 
(AMO)) generated for primary substrate utilization (secondary substrate not utilized as carbon 
or energy source), and mixed substrate growth, where TOrCs are used as primary and 
secondary substrate sources and are mineralized by microorganisms (Luo et al., 2014; Vader et 
al., 2000). Co-metabolism particularly by ammonia monooxygenase is further reviewed in 
subsection 2.4.2.  
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In general, the extent of biodegradation depends on TOrC properties such as hydrophobicity, 
volatility, and partitioning properties as well as biological properties such as distribution, 
abundance, and diversity of microbial communities. In suspended growth systems, operating 
parameters such as solids retention time (SRT), hydraulic retention time (HRT), redox 
conditions, temperature, and pH can impact biodegradation. In attached growth applications 
(i.e., biofiltration), operating parameters such as acclimation period, empty bed contact time 
(EBCT), and media type affect biodegradation. In-depth reviews of effects of operating 
parameters specifically on AOMs in attached growth applications can be found in subsections 
2.3.2.1 to 2.3.2.8. For effective co-metabolism to occur, the concentrations of primary and 
secondary substrates must be balanced because high secondary substrate concentrations 
combined with low primary substrate concentrations can lead to decreased degradation due to 
lack of carbon and energy sources and/or toxicity of secondary substrate (Ghosh et al., 2005). 
Furthermore, the properties of microbial communities and biomass including biomass 
concentration, distribution of nutrients, and microbial diversity and interaction must be 
understood to optimize biodegradation (dos Santos & Daniel, 2020). A full table of removals of 
various TOrCs through biofiltrations processes can be found in Appendix A. 
 
2.2.2.2.1 Biomass concentration 
The concentration of biomass can be a useful indicator of the abundance and activity of 
microbial communities that perform biodegradation; however, concentration of biomass is not 
always directly correlated to biodegradation. Therefore, measurements based on adenosine 
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triphosphate (ATP) are a more reliable indicator of biological activity (Greenstein et al., 2018; 
Pharand et al., 2014; Velten et al., 2007). However, even biomass concentration measurements 
using ATP still do not account for diversity or the structure and functional capacity of the 
microbial community and may not accurately indicate the degree of TOrC biodegradation 
(Greenstein et al., 2018).   
 
2.2.2.2.2 Distribution of nutrients 
The depth of the biofiltration column also creates a vertical spatial distribution of nutrients and 
therefore concentration and diversity of microbial communities. In typical downflow operation, 
the top of the biofilter will receive the greatest concentration of nutrients including carbon, 
organics, and dissolved oxygen (DO) leading to higher biomass concentrations (Boon et al., 
2011; Liao et al., 2013; Tatari et al., 2016). Studies have found that in the case of ammonia 
removal the majority of nitritation has been observed in the top layer of biofilters (Feng et al., 
2012), even up to 10 times higher than middle and bottom layers (Tatari et al., 2016). Microbial 
diversity has been shown to increase with biofilter depth in one study (Boon et al., 2011). 
However, more research needs to be conducted in this area to better understand the impact of 
depth on diversity (dos Santos & Daniel, 2020).  
 
17 
2.2.2.2.3 Microbial diversity and interaction 
The diversity of microbial communities and their cooperative or competitive relationships 
within biofilms is affected by operating conditions which in turn affect the removal of target 
contaminants. A good example of this is the relationship between aerobic heterotrophs and 
aerobic nitrifying autotrophs that compete for DO and substrates. Due to this competitive 
relationship, an increase in substrate will have severe negative impacts to nitrification as 
aerobic heterotrophs will out compete the nitrifiers (Wijeyekoon et al., 2004). Similarly, if 
insufficient DO is present then nitrifying activity will be negatively impacted (Prinčič et al., 1998; 
Xiang et al., 2013). An example of cooperative degradation was observed where degradation of 
geosmin occurred only when three bacteria were present together (none of the three bacteria 
could initiate metabolism of geosmin in isolation), therefore complementation of metabolic 
deficiencies was observed (Hoefel et al., 2006). Unfortunately, these dynamic relationships can 
be complex and there is a lack of research in this area with respect to reclaimed water (dos 
Santos & Daniel, 2020). However, one study has found positive correlations between AOB and 
Comammox abundance in multiple cases indicating that at least AOBs and Comammox may 
have a cooperative relationship in wastewater systems (Cotto et al., 2020). 
 
2.3 Ammonia Oxidizers  
The widely used approach for conventional biological treatment processes worldwide by 
WWTPs includes the removal of ammonia (nitrification) by AOMs including AOBs, AOAs, and 
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Comammox. The first step in this extensively studied and utilized process of nitrification is 
known as nitritation, which is performed by AOBs, AOAs, and Comammox, and can be 
described by Equation 1.  
Equation 1 
2𝑁𝐻4
+ + 3𝑂2 → 2𝑁𝑂2
− + 4𝐻+ + 2𝐻2𝑂  
There are two enzymes involved in this process: the first is AMO which catalyzes the reaction in 
Equation 2 and the second is hydroxylamine oxidoreductase (HAO) which catalyzes the reaction 
in Equation 3 (WEF, 2010). 
Equation 2 
2𝐻+ + 𝑁𝐻3 + 𝑂2 + 2𝑒
− → 𝑁𝐻2𝑂𝐻 + 𝐻2𝑂  
Equation 3 
𝑁𝐻2𝑂𝐻 + 𝐻2𝑂 → 𝑁𝑂2
− + 5𝐻+ + 4𝑒−  
The second step of nitrification, nitratation, which is typically performed by NOB and 
Comammox, is described by Equation 4. 
Equation 4 
2𝑁𝑂2
− + 𝑂2 → 2𝑁𝑂3
− 
The complete oxidation reaction is described by Equation 5. 
Equation 5 
𝑁𝐻4
+ + 2𝑂2 → 𝑁𝑂3
− + 2𝐻+ + 𝐻2𝑂 
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While AOBs and AOAs can only perform the first step, Comammox are capable of performing 
the entire nitrification process alone. 
 
2.3.1 Background and Occurrence 
The occurrence of AOBs in water and wastewater was discovered and has been studied since 
the 1800’s while AOAs were identified and studied since 2005 (Könneke et al., 2005). The AOBs 
found in wastewater treatment are divided into two genera – Nitrosomonas and Nitrosospira 
(Metcalf & Eddy et al., 2013). In 2015, Comammox and their ability to oxidize ammonia to 
nitrite were revealed. Comammox are able to convert nitrite into nitrate, which was previously 
thought to be completed by NOB alone (Daims et al., 2015; Van Kessel et al., 2015). Comammox 
were found in WWTPs (Wang et al., 2018) and drinking water systems (Wang et al., 2017). AOB, 
AOA, NOB, and Comammox taxonomy and key enzymes are presented in Table 2. AOBs and 
AOAs were detected in wastewater biotrickling filter systems as well as drinking water 
treatment and distribution systems although it is unclear which group dominates (Roy et al., 
2017, 2020). Biotrickling filter colonization by AOBs and AOAs depends on temperature, 
ammonia availability with AOB being more abundant at high ammonia and AOA being 




Table 2: AOB, AOA, NOB, and Comammox taxonomy and key enzymes 
Taxonomy Key Enzymes Genera References 
AOB AMO, HAO 
Nitrosomonas 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrosospira 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrosovibrio 
Schoch et al. (2020); 
Sayer t al. (2019) 
AOA AMO, HAO 
Nitrosopumilus 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrososphaera 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrosoarchaeum 
Schoch et al. (2020); 






Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrococcus 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrospira 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrospina 
Schoch et al. (2020); 
Sayer t al. (2019) 
Nitrotoga 
Schoch et al. (2020); 
Sayer t al. (2019) 
Comammox AMO, HAO, NXR 
Candidatus Nitrospira inopinata Daims et al. (2015) 
Candidatus Nitrospira kreftii Sakoula et al. (2021) 
Candidatus Nitrospira nitrificans van Kessel et al. (2015) 




In conventional WWTPs, AOMs play a role in the secondary treatment stage performing the 
nitritation (AOBs and AOAs) and nitrification (Comammox) processes. Beyond this conventional 
role, researchers have observed TOrC removal in suspended growth secondary treatment 
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stages correlated well with nitrification which may be explained by longer HRT (increased time 
for biodegradation), longer SRT (increased diversity), decreased food to microorganism ratio 
(need to degrade more difficult compounds), or co-oxidation by AMO enzyme (Margot et al., 
2016). In attached growth applications (i.e. biofiltration), these bacterial communities have the 
capacity to  effectively degrade naturally occurring taste and odor causing compounds, 
oxidation by-products, and inorganic compounds such as ammonium/ammonia converting 
them to nitrite and nitrate; while TOrC removal varies by compound (Brown et al., 2015, 2018; 
Greenstein et al., 2018).  
 
2.3.2.1 Impact of Ammonia Concentration 
Studies evaluating the impact of ammonia concentration on AOMs (especially AOAs) are mainly 
limited to suspended growth applications while studies evaluating Comammox are extremely 
rare. Studies have shown that in general as the concentration of ammonia increases the 
abundance of AOBs increases but the abundance of AOAs decreases while definite conclusions 
on Comammox abundance have yet to be drawn (Limpiyakorn et al., 2011; Roy et al., 2017; 
Sauder et al., 2012; Sonthiphand & Limpiyakorn, 2011).  
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2.3.2.2 Impact of Chloramine Concentration 
Unlike stronger oxidants such as chlorine or ozone, biological communities may tolerate and 
even utilize beneficial nutrients (ammonia) from monochloramines (Cl2 to NH3-N ratio between 
3 and 5) at low concentrations (American Water Works Association & American Society of Civil 
Engineers, 2012). However higher monochloramine concentrations have been found to halt 
ammonia oxidizing activity: >1 mg Cl2/L (Maestre et al., 2013), >0.65mg Cl2/L (Roy et al., 2020). 
Inhibition of AOBs occurred at lower monochloramine concentrations than AOAs indicating that 
AOAs are more tolerant to chloramine exposure (Roy et al., 2020). The impacts of chloramine 
concentrations on Comammox communities have yet to be determined. 
 
2.3.2.3 Impact of pH 
Microbial communities in water and wastewater treatment prefer a pH around neutral typically 
in the range of 6 to 9. One study has found that nitrifying activity of AOBs is highest around 7 
with very low nitrification occurring at pH 6, but effective nitrification still occurring as high as 
pH 8.2 although changes in community structure were observed (Prinčič et al., 1998). Another 
study found that amoA gene and transcript copies were highest at pH 6.9 with a significant 
decrease below pH 6.5 and a slight decrease at pH 7.3-7.5 in soil (Nicol et al., 2008). However, 
AOAs dominated the AOM population with a slight decreasing trend in amoA gene copies from 
acidic to basic and a significant decreasing trend in amoA transcript copies from acidic to basic 
conditions (Nicol et al., 2008). 
23 
 
2.3.2.4 Impact of Temperature 
Studies have shown that temperature can greatly affect the treatment efficacy of biofilters 
employing AOBs and AOAs which tend to exhibit increased abundance and activity in warmer 
temperatures (Roy et al., 2017; Sauder et al., 2012). One study showed that effluent 
contaminant levels related to AOA and AOB activity spiked when influent water was below 10°C 
indicating a decrease in activity and biodegradation efficacy of AOM communities at colder 
temperature (Kasuga et al., 2010). Another study showed that different clusters of Nitrosospira 
dominated depending on temperature and nitrifying activity decreased in colder temperatures 
with optimum activity from 15°C to 25°C (Avrahami & Conrad, 2003). Other studies have been 
in agreement that AOA and AOB abundance significantly positively correlated with warmer 
temperatures (Roy et al., 2017; Sauder et al., 2012). 
 
2.3.2.5 Impact of Dissolved Oxygen 
DO can be a key operating parameter in the nitritation and nitrification processes because of 
the competition between heterotrophic and autotrophic nitrifying bacteria for DO 
consumption. When there is insufficient DO, the competition between heterotrophic and 
autotrophic nitrifying bacteria will limit ammonia removal. This relationship between DO and 
nitrification has been observed in the conventional aerobic/anaerobic process  (Guo et al., 
2009) which is in agreement with the biofiltration process (Prinčič et al., 1998; Xiang et al., 
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2013). It was found that DO content (after acclimation for ammonia removal) was around 20% 
consumed when competition with heterotrophs reached an equilibrium (Prinčič et al., 1998; 
Xiang et al., 2013).  
 
2.3.2.6 Impact of Acclimation Period 
The acclimation period which is the “lag period” before steady state removal of a contaminant 
is observed is a critical design parameter. This likely occurs due to a combination of time 
required for microbial communities to become sufficiently established to provide degradation 
(Klitzke et al., 2010), time required for production of enzymes (Smith et al., 2008), degradation 
of preferential organics before target compounds, and acclimation to inhibiting compounds (Ho 
et al., 2012). The acclimation period varies widely for different contaminants, or degradation 
may not occur at all in the case of some recalcitrant TOrCs (Zearley & Summers, 2012). 
Acclimation periods will also vary depending on the source water and type of media being used. 
For example, typical acclimation periods for ammonia removal using BAC can vary from around 
40 days (Xiang et al., 2013) to around 110 days (Greenstein et al., 2018). Two studies have 
provided acclimation periods for a comprehensive range of TOrCs using BAC (Greenstein et al., 




2.3.2.7 Impact of EBCT 
The EBCT is a design parameter which is defined as the bulk volume of the biofilter divided by 
the flow which is typically around 5 to 15 minutes but sometimes as high as 30 minutes. In 
general, higher EBCTs will lead to increased degradation; however, this is dependent on the 
TOrCs and temperature (Hallé et al., 2015; Sari et al., 2020; Zearley & Summers, 2012). Some 
readily biodegradable TOrCs may require less than 5 mins of EBCT whereas recalcitrant TOrCs 
may not be biodegraded even at high EBCT. Therefore, an EBCT between 10-15 mins is often 
chosen for TOrC degradation (Greenstein et al., 2018; Hallé et al., 2015; Zearley & Summers, 
2012). 
 
2.3.2.8 Impact of Media Type  
The three types of media in biofiltration are inert (i.e., anthracite, sand), adsorptive (i.e., GAC), 
and biologically active (i.e., BAC). While BAC is exhausted GAC and therefore may still possess 
very limited adsorptive potential, its primary mechanism is biological removal. These media 
have both been shown to support bacterial communities including AOMs; however, GAC is 
more porous than anthracite and sand allowing development of more biomass (Wang et al., 
2007). A study comparing AOM development and activity on different media has not been 
conducted and while some studies have observed shorter acclimation periods, increased 
activity and increased removal of contaminants in GAC over inert media (Greenstein et al., 
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2018; Zhang et al., 2017), other studies have found this is not always the case (Pharand et al., 
2014). 
 
2.3.2.9 Activity Inhibition 
Ammonia, disinfectants such as chlorine or chloramines, and oxygen are not the only chemical 
compounds that may inhibit AOMs. There are other inorganic and organic compounds that may 
also inhibit AOM activity either intentionally or unintentionally. The most common intentionally 
used AMO inhibitor is allylthiourea (ATU) which inhibits AOB activity at very low concentrations 
(Lehtovirta-Morley et al., 2013; Men et al., 2017). Other organics that significantly inhibit AOM 
activity include 1-alkynes (up to C10) (Hyman et al., 1988), dicyandiamide (DCD) (Lehtovirta-
Morley et al., 2013; Shen et al., 2012), nitrapyrin (Iizumi et al., 1998; Lehtovirta-Morley et al., 
2013), phenols (Iizumi et al., 1998), and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxide-3-oxyl 
(PTIO) for AOAs (Jung et al., 2014; Yan et al., 2012). PTIO is often the research standard to 
intentionally inhibit AOAs whereas the others may simply be present in treatable water or less 
frequently used.  Besides organics, other common inhibitors found in treatable water include 
heavy metals such as copper, cadmium, zinc, and others can also significantly inhibit AOM 
activity (Li et al., 2016). Additionally, some TOrCs (i.e. ibuprofen, carbamazepine, naproxen, 
ketoprofen, diclofenac, tetracycline, and clofibric acid) have been found to inhibit AOMs at 




2.4.1 General Description 
Unlike direct catabolism (primary substrate utilization), cometabolism (secondary substrate 
utilization), is the fortuitous biodegradation of compounds by enzymes used for primary 
substrate metabolism which allows bacterial communities to remove some compounds such as 
hazardous organics and TOrCs (Zearley & Summers, 2012). The primary substrates are present 
at concentrations high enough to act as carbon and energy sources which is wastewater is 
biodegradable organic matter (Benner et al., 2013). Cometabolism (secondary substrate 
utilization) occurs with secondary substrates that are present at levels too low to act as carbon 
and energy sources and do not induce the enzyme responsible for degradation but are still 
degraded by non-specific enzymes such as AMO (Benner et al., 2013). 
 
2.4.2 Co-metabolism by Ammonia Oxidizers 
The abundance of AOMs is typically quantified by the amount of amoA gene present. Although 
amoB and amoC are also relevant to the AOM community, amoA is the most significant and 
well-studied (Nsenga Kumwimba & Meng, 2019). The AMO enzyme is an intracellular oxidative 
enzyme that primarily catalyzes ammonia to nitrite but has been observed to be substrate 
promiscuous and may co-metabolize various TOrCs as well, likely through hydroxylation 
reactions (Margot et al., 2016). Although extensive studies linking TOrC degradation to 
nitrifying activity exist and some even more specifically to AOMs, the exact biotransformation 
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mechanisms remain up for debate. The relationship between AOMs (AMO enzyme) to co-
metabolize more traditional organics such as methane and alkenes, chlorinated organics 
(trichloroethylene (TCE), 1,2-dichloroethane (DCE), vinyl chloride (VC), and trinitrotoluene 
(TNT)) as well as wide range of aromatic, aliphatic, and halogenated compounds  (i.e. 
hydrocarbons) and trihalomethanes (THMs) has been well documented (Fischer & Majewsky, 
2014; Hazen, 2010; Nsenga Kumwimba & Meng, 2019; Wahman et al., 2006; Yu et al., 2018).  
Of the emerging TOrCs, the activity of AMO enzyme has correlated with biodegradation via co-
metabolism of atenolol (Sathyamoorthy et al., 2013; Xu, Radjenovic, et al., 2017), bisphenol A 
(BPA), cybutryne, iohexol, naproxen, terbutryn (Margot et al., 2016), acyclovir (Xu, Yuan, et al., 
2017), sulfamethoxazole (Kassotaki et al., 2016), triclosan (Roh et al., 2009), 17α-
ethinylestradiol (Yi & Harper, 2007), and ibuprofen (Fernandez-Fontaina et al., 2016). Previously 
mentioned studies focused mainly on AOBs which are the most extensively studied and a 
comprehensive review on AOB cometabolism was completed by (Nsenga Kumwimba & Meng, 
2019). So far, the only AOA that has been studied for cometabolism is Nitrososphaera gargensis 
which has been found to degrade two tertiary amines (mianserin and ranitidine) (Han et al., 
2019; Men et al., 2016), seven sulfonamides (sulfadiazine, sulfamethazine, sulfamerazine, 
sulfamethoxazole, sulfadoxine, sulfamonomethoxine, and sulfathiazole) (Zhou et al., 2019), the 
herbicide asulam and fungicide fenhexamid (Han et al., 2019). 
The only Comammox that has been studied for cometabolism is Nitrospira inopinata which was 
able to degrade five sulfonamides (sulfamethazine, sulfamerazine, sulfadiazine, sulfadoxine, 
sulfamonomethoxine) (Zhou et al., 2019) and asulam, fenhexamid, mianserin, ranitidine, and 
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carbendazim (fungicide) (Han et al., 2019). While some studies find that cometabolism is likely 
the main mechanism in TOrC biodegradation (Khunjar et al., 2011; Yi & Harper, 2007), other 
studies have found that cometabolism may not be the main mechanism for most TOrC 
degradation (Margot et al., 2016). The complex nature of biofilm and cometabolism of TOrCs 
makes it difficult to distinguish the causality of TOrC degradation and even more difficult to 
distinguish the precise degradation mechanisms, but some have been suggested. 
 
2.4.2.1 Proposed Biotransformation/Biodegradation Mechanisms 
The mechanisms for cometabolism are dependent on the activity of the AMO enzyme which 
has been demonstrated to contain metal ions—generally copper although iron may also be 
present (Gilch et al., 2010; Nsenga Kumwimba & Meng, 2019; Yi & Harper, 2007). It is also 
possible that the AMO enzyme active site has two faces where one has an oxygen activating 
region and the other has a hydrophobic pocket that would capture TOrCs creating a reaction 
with the oxygen activating face (Tran et al., 2013; Yi & Harper, 2007).  
It is proposed that biodegradation of 17α-ethinylestradiol occurs due to electrons entering a 
catalytic cycle involving a binuclear copper site located in the active site for AMO. Oxygen will 
then react to convert Cu(I) to Cu(II), but oxygen will remain bound as a peroxide ion. Finally, the  
oxygenated form of AMO will react with other substrates such as TOrCs to produce the Cu(II) 
form (Yi & Harper, 2007). Another study proposed that AOBs may directly metabolize 17α-
ethinylestradiol at concentrations above 150 µg/l but can biotransform 17α-ethinylestradiol at 
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lower concentrations through a sulfonation reaction catalyzed by sulfotransferase homologues 
(Khunjar et al., 2011). 
Other TOrCs may follow different transformation pathways such as deamination or 
hydroxylation. This was observed in the case of sulfonamides as well as oxidation of the amine 
group to a hydroxyl group, and oxidation of the amine group into nitro group (Zhou et al., 
2019). It was found that the AMO enzyme for AOB, AOA, and Comammox differed on ammonia 
affinity and therefore carry out different transformation pathways. The AOA carried out 
deamination, hydroxylation, and nitration whereas the AOB carried out mainly deamination 
and the Comammox performed only deamination reactions (Zhou et al., 2019). 
 
2.4.2.2 Research Challenges 
It is important to note that the current state of knowledge on the relationship between AOMs 
and TOrC degradation via cometabolism faces some challenges that have been pointed out in 
previous reviews. Research can mainly be divided into laboratory-scale real-world mixed culture 
biofilms or laboratory-scale pure-culture batch experiments. Unfortunately, cometabolism 
batch studies specifically using the AMO enzyme are essentially infeasible due to issues with 
retaining activity after purification (Tran et al., 2013; Yu et al., 2018). With real world biofilms 
there are two main methods that have determined this relationship – a correlation between 
nitrification and TOrC degradation or inhibitor studies. The first method is a less specific 
correlation and does not account for other microbes (i.e., heterotrophs) that may be 
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significantly contributing to degradation or potentially have a codependent relationship with 
AOMs. One study even found that certain TOrC degradation rates correlated with nitrification 
but not AMO activity (Helbling et al., 2012). 
The second method is more specific where an inhibitor (most commonly ATU) is used to isolate 
the AOMs and compare biodegradation rates; however, the inhibition effects of ATU have been 
found to be not as specific to AOMs as previously thought meaning other microbes (specifically 
heterotrophs) may compromise this method (Men et al., 2017). Existing laboratory batch 
studies focused primarily on AOBs while AOA and Comammox studies are very limited. 
Furthermore, the assumption that cometabolism is the only mechanism for degrading TOrCs 
because concentrations are so low that TOrCs cannot be used as nutrient sources may not be 
entirely true. Recently two studies have observed abiotic transformation of the TOrCs 
mianserin, indomethacin, ranitidine, furosemide, and fenhexamid (Yu et al., 2018) and 
sulfonamides (sulfadiazine, sulfamethazine, sulfamethoxazole, sulfadoxine, sulfamerazine, 
sulfamonomethoxine, and sulfathiazole) (Zhou et al., 2019) via hydroxylamine reactions which 
may be overlooked in previous studies. Finally, given the vast majority of studies are conducted 
at the laboratory scale there is still a need for pilot-scale and full-scale cometabolism studies 
(Nsenga Kumwimba & Meng, 2019). 
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Chapter 3: Experimental Approach 
3.1 Materials and Treated Wastewater 
The following chemicals were used: ammonium sulfate (ACS grade and purity, VWR Chemicals, 
Solon, Ohio), sodium hypochlorite (Acros Organics, Geel, Belgium, 5% active Chlorine), 
allylthiourea (Acros Organics, Fair Lawn, NJ, 98%), and PTIO (Enzo Life Sciences, Farmingdale, 




Figure 1: Treatment train of CCWRD 
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Figure 1 depicts the treatment train of the Clark County Water Reclamation District (CCWRD), a 
full-scale water reclamation facility located in Las Vegas, NV. Treated secondary effluent was 
obtained following the secondary clarification process and was used as the feed water for the 
BAC pilot. The secondary biological treatment process at CCWRD primarily targets phosphorus 
removal and also achieves full nitrification and partial denitrification. Therefore, the secondary 
effluent contains low concentrations of ammonia, nitrite, and phosphorus but relatively high 




Table 3: Typical characteristics of secondary effluent from CCWRD 
Parameter Units Secondary Effluent 
Alkalinity mg/L 121 + 2 
Ammonia as N mg/L 0.122 + 0.022 
Bromide mg/L 0.180 + 0.015 
Conductivity µs/cm 1557 + 16 
Dissolved organic carbon mg/L 6.9 + 0.4 
Nitrate as N mg/L 13.1 + 0.8 
Nitrite as N mg/L 0.051 + 0.014 
Ortho phosphate as P mg/L 0.0768 + 0.0174 
pH S.U. 6.91 + 0.05 
Total dissolved nitrogen mg/L 12.3 + 0.4 
Temperature °C 23.8 + 1.9 
UV absorbance at 254 nm /cm 0.132 + 0.006 
UV absorbance at 280 nm /cm 0.1014 + 0.0048 
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3.2 Experimental Setup 
Three parallel continuous downflow columns (PVC, 1” ID x 37” height) containing 10+ year-old 
exhausted GAC (Filtrasorb F400) that is now biological activated carbon (BAC) were used. Each 
column was operated with a target empty bed contact time (EBCT) of 10 minutes 
corresponding to a flow rate of approximately 45 mL/min supplied by peristaltic pumps. 
Secondary effluent was acquired at an inlet point about half the depth of an equalization tank 
to prevent excess settled solids from clogging the BAFs. One column served as a control column 
which was fed only secondary effluent. Another column served as the ammonia column which 
was continuously fed a 12 mg N/L ammonia solution inline by a peristaltic pump from a 10 
gallon tank at a flow rate of 9 mL/min to achieve a continuous target dose of 2 mg N/L. The final 
column served as the chloramine column which was continuously fed 6 mg Cl2/L chlorine and 
0.7 mg N/L ammonia solutions inline sequentially by peristaltic pumps from two 10-gallon tanks 
at flow rates of 9 mL/min each to achieve a continuous monochloramine (3 Cl2:1 NH3-N ratio) 
dose of 0.3 mg Cl2/L when accounting for instantaneous chlorine demand. All relevant water 
quality parameters were adjusted for the differing dilution effects in the experimental columns. 
Inline static mixers were employed directly after the injection point to ensure proper mixing of 
all chemical feeds. Figures 2 and 3 show images of the experimental setup and Figure 4 shows 
the chemical dosing setup. Each column was backwashed (upflow) with secondary effluent for 
around 20 minutes with peak flow of 145 mL/min approximately every 24 h, Monday through 
Friday, with approximately 72 h of continuous operation over every other weekend. To prevent 
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excess solids buildup and clogging in the equalization tank, the system was shut down and the 




Figure 2: BAC column dosing: BAF1 fed with secondary 
effluent; BAF2 fed with secondary effluent and 2 mg N/L of 
ammonia; BAF 3 fed with secondary effluent and 0.3 mg 
Cl2/L of monochloramine 
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Figure 3: Experimental column setup 
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Figure 4: Feed and chemical pump setup 
 
 
3.3 Experimental Operation and Sampling Program 
3.3.1 Startup/Acclimation 
For the three BAF columns, one column served as a control and was fed secondary effluent 
only, another column was spiked with ammonia, and the third column was spiked with 
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chloramine solution (generated by the inline mixer from the dosed chlorine and ammonia) over 
a period of 16 weeks with five major monthly sampling events.  
The startup/acclimation period began in late November 2020 and all three columns were 
operated with only secondary effluent for four weeks. Then, in late December 2020 ammonia 
was dosed into BAF2 at the target concentration of 2 mg N/L for another four weeks before the 
first major sampling event. BAF3 was operated with only secondary effluent until one week 
before the first major sampling event where the target dose of 0.3 mg Cl2/L monochloramine 
was applied. These acclimation and chemical dosing periods were in place to ensure that the 
microbial community is established and stable prior to starting the experimental components of 
the study. Initial water quality parameters (ammonia and total/free chlorine) were monitored 
weekly at this time and acclimation was complete when consistent ammonia removal was 
observed. 
 
3.3.2 Operation and Sampling Plan 
Following acclimation, experimental sampling occurred over 16 weeks of operation. Feed water 
was analyzed weekly for ammonia, nitrate, and nitrite while all three biofilter effluents were 
analyzed weekly for ammonia, nitrate, nitrite, and ATP with total/free chlorine being analyzed 
for the chloraminated column. Additionally, pH, temperature, and conductivity were measured 
monthly for feed water. Monthly sampling also included feed water and biofilter effluent water 
samples which were later analyzed for TOrCs and AOM gene abundance. BAC media was also 
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sampled monthly from two depths within each column and then stored at -20°C until biological 
analysis using qPCR to determine the abundance of AOBs, AOAs, and Comammox target genes.  
 
3.3.3 Selection of Ammonia and Chloramine Doses  
While ammonia is present in CCWRD secondary effluent, the concentration is very low (ranging 
from 0-0.15 mg N/L) and it is common to have very little ammonia in biofiltration systems, 
therefore an ammonia source was added prior to the biofilters. Monochloramine 
concentrations exceeding 1 mg Cl2/L have been found to halt ammonia oxidizing activity of 
AOBs (Maestre et al., 2013) so a monochloramine dose of 0.3 mg Cl2/L was selected for BAF3 
(Roy et al., 2020). An ammonia dose of 2 mg N/L was selected for BAF2 to promote AOB 
development. The low dose of ammonia from the decomposition of chloramines was expected 
to promote development of AOAs which are abundant in low ammonia concentrations, 
whereas the higher dose of ammonia into the other column will promote development of AOBs 
which are abundant in high ammonia concentrations, while Comammox may be present in both 
(Roots et al., 2019; Sauder et al., 2012; Sonthiphand & Limpiyakorn, 2011).  
 
3.3.4 Selection of TOrCs 
Table 4 shows the 17 different TOrCs to be evaluated, their occurrence in secondary effluent 
from previous sampling, biodegradability from literature, and which TOrCs were selected as 
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potential indicators to measure biological treatment success. Indicator selection was based on 
occurrence and biodegradability providing a range of TOrCs that are more readily 
biodegradable to TOrCs that are moderately biodegrade. From previous literature atenolol has 
been more readily biodegraded in some studies (Dickenson et al., 2018; Zhang et al., 2017) but 
showed moderate removal in another (Rattier et al., 2014). Meprobamate has also shown more 
moderate removal in previous literature (Dickenson et al., 2018) although few studies have 
evaluated its removal in biofilters. The removal of N,N-Diethyl-meta-toluamide (DEET) has 
varied across some studies with low removal (Dickenson et al., 2018; Zhang et al., 2017) to 
somewhat higher removal (Hallé et al., 2015; Rattier et al., 2014) which will provide an 
adequate indicator that it is not readily biodegradable, but not unbiodegradable. Naproxen, 
acetaminophen, caffeine, and ibuprofen will serve as the highly biodegradable indicators that 
have been shown to be removed very successfully in some studies (Dickenson et al., 2018; Hallé 
et al., 2015; Zearley & Summers, 2012; Zhang et al., 2017). Due to minimal or nonexistent 
concentrations of acetaminophen, caffeine, naproxen, and ibuprofen occurring in secondary 
effluent these four TOrCs were spiked into the secondary effluent at a concentration of 1 µg/L 






Table 4: TOrC occurrence, biodegradability, and selection as indicator 
TOrCs Occurrence in Pilot Influent Biodegradability Indicator  
Acetaminophen None-Very Low* High Yes 
Caffeine None-Low* High Yes 
Ibuprofen None-Very Low* High Yes 
Naproxen Low* Moderate-High Yes 
Atenolol Moderate Moderate-High Yes 
Trimethoprim Moderate Moderate-High  
Triclosan Very Low Moderate-High  
Gemfibrozil Very Low Moderate-High  
DEET Moderate Moderate Yes 
Meprobamate Moderate Low-Moderate Yes 
Sulfamethoxazole High Low-Moderate  
Fluoxetine Low Low-Moderate  
Carbamazepine Moderate Low  
TCEP Moderate Low  
Sucralose Very High Low  
Primidone Moderate Low  
Triclocarban None-Very Low Low  
*Spiked at target concentration of 1 µg/L in the secondary effluent during sample days. 
 
 
3.3.5 AOA and AOB Inhibition Experiments 
The most commonly used AMO-specific inhibitor is ATU, which inhibits AOB activity at very low 
concentrations (Lehtovirta-Morley et al., 2013; Men et al., 2017). The most common inhibitor 
for AOAs is PTIO (2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxide-3-oxyl) which also provides 
inhibition at low concentrations (Jung et al., 2014; Yan et al., 2012). It has been observed that 
ATU is capable of total instantaneous inhibition of AOBs at concentrations of 86 µM (Ginestet 
et al., 1998). Total instantaneous inhibition of AOAs has also been observed with a dose of 100 
µM of PTIO (Yan et al., 2012). To provide complete inhibition of both AOB and AOA populations, 
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both ATU and PTIO were dosed at 112 and 107 µM, respectively for 3 bed volumes 
approximately 24 h prior to the final monthly sampling event.  
 
3.4 Analytical Methods 
3.4.1 Analysis of TOrCs 
To provide comprehensive indicator analysis, a variety of 17 TOrCs were evaluated via solid 
phase extraction followed by liquid chromatography tandem mass spectrometry (LC-MS/MS) 
on a monthly basis. The procedure used by the Southern Nevada Water Authority’s applied 
research and development laboratory followed the procedure outlined in Vanderford & Snyder 
(2006).   
 
3.4.2 Biological Analysis 
3.4.2.1 DNA Extraction, Visualization, and Quantification 
A major objective of this study was to investigate a possible relationship between AOMs and 
TOrC degradation, which was achieved with quantitative polymerase chain reaction (qPCR) 
analyses and LC-MS/MS. First, DNA was extracted from biofilter media, biofilter effluents, and 
suspended solids collected from biofilter effluents with 0.2-µm pore-size membrane filters 
(Sterilized Supor disk filter, Pall Laboratory) using a membrane filtration apparatus. The actual 
DNA extraction process followed a method adapted from Gabor et al. (2003) for biofilter media 
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or the use of commercial kits for biofilter effluent (PureLink Viral RNA/DNA mini kit) and 
suspended solids (DNeasy PowerBiofilm Kit). DNA was then visualized by gel electrophoresis to 
examine DNA quality using the Invitrogen E-Gel Power Snap Electrophoresis Device with SYBR 
Safe E-Gel agarose gels (1.2%) for a 15 minute runtime. DNA was also quantified with Qubit 4 
Fluorometer and the Qubit dsDNA HS Assay Kit.  
 
3.4.2.2 Quantitative polymerase chain reaction (qPCR) assays 
Four SYBR-based qPCR assays were used to quantify bacteria by targeting the bacterial 16S 
rRNA gene (515F-806R qPCR assay), ammonia oxidizing bacteria (AOB qPCR), ammonia oxidizing 
archaea (AOA qPCR), and Comammox (COM qPCR assay). Assays were run on a Bio-Rad CFX384 
Touch Real-Time PCR Detection System. All primers and gBlock standards were acquired from 








Table 5: qPCR assay summary, primers, and annealing temperature 





16S rRNA gene 515-806R 50°C 
















Reactions were run in a 10 μL final volume containing 1 μL of template DNA and 9 μL of 
Mastermix composed of 5 μL of iTaq SYBR Green Universal Mastermix (Biorad), 0.4 μM of each 
primer and variable amount of water to reach 10 μL total volume (Table 5). Cycling conditions 
were as follows: initial denaturation at 95°C for 2 min, followed by denaturation at 95°C for 5 
seconds, annealing at assay specific temperature (Table 4) for 1 minute and extension at 72°C 
for 1 minute. Total number of cycles was 45 followed by a melt curve from 65°C to 95°C for 5 
seconds at 0.5°C intervals for all assays. In each assay, all samples were analyzed in triplicates 
and outliers were removed based on melt temperature or standard deviation within the 
triplicate. Gene copy numbers were then corrected using the equivalent sample volume to find 
concentration in either gene copies per liter water or gene copies per gram media. The AOA, 
AOB, and Comammox assays were divided by 16S rRNA to find a normalized percent value to 
correct for potential differences in sample-specific DNA extraction efficiencies. 
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3.4.3 Bulk Parameter Analyses 
Ammonia, nitrate, nitrite, and free and total chlorine were analyzed weekly using a HACH 
DR6000 Laboratory Spectrophotometer with the following kits: HACH TNTPlus 866/867 (free 
and total chlorine) using methods 10231 and 10232 (the diethyl-p-phenylenediamine or DPD 
method) respectively, HACH TNTPlus 830 (NH3-N ultra-low range) using method 10205 (the 
salicylate method), HACH TNTPlus 836 (NO3-N high range) using method 10206 (the 
dimethylphenol method), HACH TNTPlus 839 (NO2-N low range) using method 10207 (the 
diazotization method). Total ATP was analyzed weekly using a handheld Hygiena Ensure ATP 
instrument with total ATP sticks. A handheld WTW pH 3310 pH probe and Fisher Scientific 
Traceable conductivity probe were used to analyze pH, temperature, and conductivity monthly.  
 
3.5 Statistical Analysis 
Paired, two tailed t-tests were performed using Microsoft Excel to evaluate differences in TOrC 
attenuation and relative abundances of AOB, AOA, and Comammox bacteria between control, 




Chapter 4: Results and Discussion 
4.1 Temperature, pH, and Conductivity 
Temperature, pH, and conductivity measurements were conducted monthly on the secondary 
effluent. The pH was consistent across all five months at an average of 6.91 + 0.05. The 
conductivity increased from the month of January 2021 to April 2021 from 1535 µs/cm to 1576 
µs/cm, which is a relatively minimal change resulting in an average of 1557 + 16 µs/cm. 
Temperature also steadily increased from January 2021 to May 2021 (corresponding to ambient 
atmospheric temperature) from 21.8 C to 27.0 C with an average of 23.8 + 1.9 C. All 
temperature, pH, and conductivity values are shown in Table 6. 
 
 
Table 6: Temperature, pH, and conductivity of secondary effluent samples 
Date pH Conductivity (µs/cm) Temperature (C) 
1/26/2021 6.99 1535 21.8 
2/23/2021 6.89 1542 22.4 
3/23/2021 6.93 1560 23.2 
4/20/2021 6.90 1576 24.7 
5/18/2021 6.85 1573 27.0 
 
 
This pH level of 6.91 + 0.05 is within the ideal range of 6.6 to 7.2 for AOM development and 
nitrification as observed in previous studies (Nicol et al., 2008; Prinčič et al., 1998). While higher 
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AOM abundance is correlated to higher water temperatures, even the lowest observed 
temperature of 21.8C is still well within the optimal temperature range of around 15C to 30C 
for AOMs (Avrahami & Conrad, 2003; Roy et al., 2017; Sauder et al., 2012). 
 
4.2 Chlorine 
Free and total chlorine measurements were conducted for the effluent of the chloraminated 
BAF weekly. The chloraminated BAF was fed a 0.3 mg Cl2/L dose of monochloramine solution 
(accounting for instantaneous demand), continuously. All free and total chlorine measurements 
in the chloraminated column effluent were detected as below the 0.05 mg Cl2/L minimum 
reporting limit (MRL) with the exception of 3/16/2021 at 0.053 mg/L. This decrease in 
chloramine concentration should be expected due to biological demand as well as adsorption 
by BAC. Exposure to chlorine and monochloramine levels this low are not shown to have any 
significant inhibitory impacts on AOMs (Maestre et al., 2013). 
 
4.3 Nutrients 
Ammonia, nitrite, and nitrate were measured weekly for secondary effluent and the effluent of 
the control, ammonia dosed, and chloramine dosed BAFs. Since the chemical dosing flows for 
the ammonia and chloramine dosed BAFs made up a substantial portion of the total influent 
flow, a dilution factor was used to correct the nutrient concentrations for the ammonia and 
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chloramine dosed BAF influents. Table 7 shows the average ammonia, nitrate, and nitrite 
concentrations along with the average removals of ammonia and nitrate by each BAF. The 
MRLs for ammonia, nitrate, and nitrite were 0.015, 5, and 0.015 mg N/L, respectively. 
 
 












Control BAF Influent 0.122 ± 0.022 
87.4 
13.1 ± 0.8 
2.68 
0.051± 0.014 
Control BAF Effluent 0.017 ± 0.021 12.7 ± 0.7 0.110± 0.048 
Ammonia BAF Influent1,2 2.102 ± 0.018 67.2 10.9 ± 0.7 -3.55 0.042± 0.012 
Ammonia BAF Effluent1 0.691 ± 0.281  11.3 ± 0.8  0.085± 0.030 
Chloramine BAF Influent1 0.093 ± 0.025 65.4 9.8 ± 1.7 -5.44 0.038± 0.012 
Chloramine BAF Effluent1 0.035 ± 0.091  10.2 ± 1.2  0.019± 0.013 
1Concentrations corrected for dilution, 2Influent was supplemented with ammonia at 2 mg N/L. 
 
 
The ammonia dosed BAF removed over 1 mg N/L of ammonia while the control and chloramine 
dosed BAFs displayed substantial ammonia removal of the low ammonia available. The control 
and chloramine dosed columns also exhibited change in nitrite concentrations of around only 
0.1 mg N/L or less meaning these changes were negligible. The control BAF displayed extremely 
limited removal of nitrate while the ammonia dosed and chloraminated BAFs displayed very 
limited nitrate production. However, when considering the conversion of over 1 mg N/L of 
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ammonia presumably to nitrate which would then be subsequently removed with in the BAF, 
nitrate removal in the ammonia dosed column may be present.  
Ammonia, nitrite, and nitrite concentrations for secondary effluent along with the effluents of 
control, ammonia dosed, and chloramine dosed BAFs are presented over time in Figures 5, 6, 





























































































































































Control BAF Influent - Ammonia Control BAF Effluent - Ammonia
Control BAF Influent - Nitrite Control BAF Effluent - Nitrite
Control BAF Influent - Nitrate Control BAF Effluent - Nitrate
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The control BAF was effective in ammonia removal, reducing the average 0.122 mg/L present in 
the secondary effluent to below the MRL in most cases. It should be noted that on the 4/27/21 
sampling day the control column experienced an extreme excess of solids that was thought to 
be a result of upstream treatment disruption, which may be responsible for the spike in 
ammonia concentration on that day. Nitrite concentrations also slightly increased throughout 
the duration of the study to just above the concentration found in the secondary effluent 
indicating that ammonia is being converted to nitrite. Nitrate concentration in the control BAF 
effluent did not vary substantially from the secondary effluent. Although the changes in 
ammonia and nitrite concentrations were very low, nitritation likely occurred in the control BAF 




Figure 6: Ammonia dosed BAF influent and effluent nitrogen speciation 
 
 
The ammonia dosed BAF was effective in ammonia removal considering the average 
concentration present in the secondary effluent was around 0.12 mg N/L combined with a 
supplemental dose of 2 mg N/L was reduced to below 1 mg N/L in all but one sampling event. It 
should be noted that the ammonia feed failed before the 2/16/21 sampling day which is the 
cause for the unusually low effluent concentration. The ammonia dosed column also cracked on 
4/9/21 and was back in operation on 4/12/21 but some of the BAC media was lost. The 



























































































































































Ammonia BAF Influent - Ammonia* Ammonia BAF Effluent - Ammonia*
Ammonia BAF Influent - Nitrite Ammonia BAF Effluent - Nitrite
Ammonia BAF Influent - Nitrate Ammonia BAF Effluent - Nitrate
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ammonia feed also experienced partial failure on 5/11/21 which may be the cause for another 
unusually low ammonia effluent. The nitrite produced was negligible compared to the 
concentrations present in secondary effluent with an average increase of only around 0.04 mg 
N/L. This means that NOBs and/or Comammox were present to convert nitrite into nitrate. The 
ammonia dosed BAF also removed around 0.4 mg N/L of nitrate. This unbalanced nitrogen 
speciation indicates that while AOMs are present to convert ammonia to nitrite and nitrate, and 
there are other microorganisms known as denitrifiers that are further completing the nitrogen 




Figure 7: Chloramine dosed BAF influent and effluent nitrogen speciation 
 
 
With the exception of the 5/18/21 sampling day, the chloramine dosed BAF exhibited excellent 
removal of the limited ammonia concentrations to below the MRL in most cases. This is a result 
of a combination of formation of monochloramine and potentially some limited primary 
substrate utilization by AOMs. The chloramine dosed BAF also experienced nitritation with very 
limited production of nitrate. It removed nitrite to often below the MRL and produced on 





























































































































































Chloramine BAF Influent - Ammonia Chloramine BAF Effluent - Ammonia
Chloramine BAF Influent - Nitrite Chloramine BAF Effluent - Nitrite
Chloramine BAF Infuent - Nitrate Chloramine BAF Effluent- Nitrate
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from the control in that less ammonia was available due to conversion to monochloramine. This 
subsequently led to minimal nitrate production.  
 
4.4 TOrCs 
Trace organic compound analysis was conducted monthly from January 2021 to May 2021 
resulting in a total of five sampling events. The first four monthly sampling events from January 
to April 2021 were conducted by adding around 500 to 900 ng/L (Figure 8) of acetaminophen, 
caffeine, ibuprofen, and naproxen to the secondary effluent (the influent for the control, 
ammonia dosed, and chloramine dosed BAFs). The final monthly sampling event in May 2021 
was similar except that around 24 hours before the sampling event 112 and 107 µM of ATU and 
PTIO were dosed together for three bed volumes into all three BAFs to inhibit AOBs and AOAs, 
respectively. Similar to the nutrient concentrations, a correction for the influent TOrC 
concentrations was utilized for the ammonia and chloramine dosed BAFs based on the dilution 
from chemical dosing.  
For the months of January to April, the TOrC concentrations and removals remained consistent; 
and average concentrations are presented in Figures 8 and Table 8 and average removals are 
presented in Figure 9. Triclocarban was not detected above the MRL for the duration of the 
study and two data points for influent acetaminophen failed QA/QC for the February and April 
analysis. It is evident that substantial removal of TOrCs from the spiked secondary effluent was 
occurring at some capacity in all three BAFs (Figure 9). In Figures 8 and 9, it can also be seen 
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that the control and chloramine dosed BAFs provided similar overall TOrC reduction while the 
ammonia dosed BAF offered the worst removal overall. Detailed data on the concentrations 
and removal percentages of the 17 TOrCs in the effluent of the control, ammonia dosed, and 
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biodegradable Low biodegradability 
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Table 8: Average TOrC concentrations from January to April, 2021 
Parameter 
Concentrations (ng/L) 
Control BAF Ammonia BAF Chloramine BAF 
Influent Effluent Influent Effluent Influent Effluent 
Acetaminophen 490 ± 10 <100 408 ± 8 <100 380 ± 37 <100 
Caffeine 655 ± 67 80 ± 9 546 ± 56 145 ± 11 509 ± 76 83 ± 11 
Ibuprofen 575 ± 74 220 ± 14 479 ± 62 313 ± 15 444 ± 59 113 ± 31 
Naproxen 823 ± 38 208 ± 38 685 ± 31 295 ± 21 635 ± 43 133 ± 11 
Atenolol 173 ± 19 123 ± 11 144 ± 16 128 ± 4 134 ± 20 125 ± 5 
Trimethoprim 168 ± 37 60 ± 2 140 ± 31 110 ± 17 128 ± 20 67 ± 5 
Triclosan 10.0 ± 2.3 6.0 ± 1.4 8.3 ± 1.9 6.7 ± 0.6 7.7 ± 1.7 2.8 ± 0.5 
Gemfibrozil 7.4 ± 1.8 11.0 ± 2.8 6.1 ± 1.5 9.5 ± 1.8 5.7 ± 1.6 8.6 ± 2.1 
DEET 213 ± 4 190 ± 12 177 ± 4 183 ± 4 165 ± 15 160 ± 24 
Meprobamate 173 ± 15 168 ± 15 144 ± 12 145 ± 9 133 ± 11 128 ± 8 
Sulfamethoxazole 743 ± 94 1000 ± 71 619 ± 78 715 ± 18 574 ± 78 803 ± 147 
Fluoxetine 38 ± 2 17 ± 2 32 ± 2 22 ± 5 30 ± 4 13 ± 3 
Carbamazepine 110 ± 7 99 ± 7 92 ± 6 89 ± 15 85 ± 8 88 ± 9 
TCEP 165 ± 23 175 ± 23 137 ± 19 153 ± 15 129 ± 27 127 ± 23 
Sucralose (x100) 578 ± 49 583 ± 61 481 ± 41 500 ± 46 449 ± 70 490 ± 64 
Primidone 165 ± 17 180 ± 21 137 ± 14 163 ± 26 128 ± 18 138 ± 16 




Figure 9: Average TOrC removal efficiencies from January to April, 2021 
 
 
Out of the highly biodegradable indicator TOrCs that were spiked, acetaminophen was reduced 
the most by all three BAFs, to below the MRLs in all cases. Removal of caffeine was similar 
between the control and chloramine dosed BAFs, but the ammonia dosed BAF removed about 
10% less. On average, the chloramine dosed BAF provided better reduction of ibuprofen and 


































































































































BAF provided higher reduction of ibuprofen and naproxen than the ammonia dosed BAF by 
about 27% and 18% (p = 0.28) on average, respectively.  
Of the moderately biodegradable indicators, surprisingly atenolol was reduced poorly by all 
three BAFs since previous studies reported 40%-80% removal (Dickenson et al., 2018; Zhang et 
al., 2017).  Removal of atenolol was the worst for the chloramine column at only 4%, while the 
ammonia BAF achieved nearly 10% removal, and the control achieving over 25% removal. The 
differences in atenolol removal compared to previous studies could be attributed to different 
EBCT, source water, and experimental conditions. DEET was also removed quite poorly with 
around 10% removal by the control, 3% by the chloraminated BAF, and a 3% increase in the 
ammonia dosed BAF. The removal of trimethoprim was high for the control BAF at around 60%; 
however, the ammonia and chloramine dosed BAFs struggled to remove trimethoprim with 
only around 25% and 24% removal. The removal of trimethoprim by BAF systems using BAC 
may also be partially attributed to adsorption by the GAC rather than biodegradation as 
observed in previous studies (Dickenson et al., 2018). Gemfibrozil concentrations increased 
significantly (p = 0.013 for control, p = 0.0003 for ammonia dosed, p = 0.004 for chloramine 
dosed) across all three BAFs which is likely a result of desorption from the BAC from previous 
use (Greenstein et al., 2018).  
All of the TOrCs that have low biodegradability were removed poorly (<25%) as expected with 
the exception of fluoxetine which is known to be readily adsorbed to GAC (Dickenson et al., 
2018). All three BAFs experienced increases in concentration or essentially no change for TCEP, 
sucralose, and primidone which is likely a result of desorption from the GAC media. 
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Sulfamethoxazole concentration increases in all three BAFs may be a the result of 
deconjugation of its transformation products acetyl-sulfamethoxazole and sulfamethoxazole-
glucuronide which are commonly present in wastewater (Stadler et al., 2015). The control and 
chloramine dosed columns exhibited 3-4% removal of meprobamate while the ammonia dosed 
columns exhibited a slight increase. Carbamazepine was best removed by the control BAF 
around 10%, while the ammonia BAF achieved a limited 3% removal, and the chloramine dosed 
BAF experienced a small increase around 3% on average. 
Overall, the addition of ammonia into the ammonia dosed BAF performed significantly worse (p 
= 0.003003) TOrC removal when compared to the control BAF for all analyzed TOrCs. 
Conversely, the addition of monochloramine improved the removal of highly biodegradable 
TOrCs, ibuprofen and naproxen, relative to the control but the improvements were not 
statistically significant (p = 0.28). For moderately biodegradable TOrCs, the impact of 
chloramination was not as positive with the only improvement over the control being removal 
of triclosan which is degraded by chloramine itself rather than via biodegradation (Drewes et 
al., 2008). The chloraminated column was able to achieve 1% better removal of meprobamate 
and experienced less increase of TCEP and primidone concentrations; however, this is not a 
major improvement. However, when compared to the ammonia dosed BAF, the chloramine 
dosed BAF performed significantly better in the average removal of all TOrCs analyzed (p = = 
0.04). The chloramine dosed BAF achieved higher removal than the ammonia dosed BAF for all 
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TOrCs except atenolol and carbamazepine, while sulfamethoxazole and sucralose increased 
slightly more in the chloraminated column than the ammonia dosed column.  
In summary, the high, moderate, and poor biodegradability properties of the TOrCs was a 
reliable indicator of removal through the BAFs with a couple exceptions due to desorption, 
limited adsorption, or chemical degradation by monochloramine. The additional ammonia did 
not improve the TOrC removal compared to the control which indicates that either the addition 
of 2 mg N/L of ammonia is either not enough to promote the development of AOMs that 
cometabolize TOrCs, or that AOA and Comammox are more important for TOrC removal than 
AOBs. The added chloramine did positively impact high biodegradability TOrC removal when 
compared to the control (but not statistically significant) and nearly all TOrC removal when 
compared to the ammonia dosed column. This indicates that a lower ammonia environment in 
the control and chloramine dosed BAFs can benefit microbial communities and is a better 
environment to target TOrC removal. This is because lower ammonia environments are 
favorable for AOA and Comammox which are hypothesized to more effectively degrade TOrCs. 
However, the lack of significant improvement in removal of moderate and low biodegradability 
TOrCs makes it difficult to conclude that the addition of chloramine provides a substantial 
benefit over the control. This is intuitive as the chloramine dose is relatively low and BAC would 
rapidly quench chloramine resulting is many similarities between the two columns. A further 
look into the effects of inhibitors ATU and PTIO on TOrC removal as well as the AOM 
communities through qPCR analysis will provide a better idea of microbial differences between 
the columns and TOrC removal elucidation. 
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4.4.1 Impact of Inhibition on TOrC Removal 
After four months of normal biological conditions, AOB and AOA inhibitors ATU and PTIO were 
dosed into all three columns at >100 µM for 3 BVs approximately 24 hours prior to the May 
2021 TOrC sampling event. While acetaminophen, caffeine, ibuprofen, and naproxen were 
dosed the day of the sampling event just as in January through April. It is unfortunate that 
influent acetaminophen analysis failed QA/QC while all BAF effluents were below the MRLs; 
and the concentration of caffeine in the influent was below the MRL (100 ng/L), likely due to 
degradation of the dosing stock over time. To compare the percent removal from the inhibited 
samples to the uninhibited samples, the percent removals in May were subtracted from the 
average percent removals in January through April.  This comparison of percent removal for all 








Table 9: TOrC percent removal differences following inhibition 
Jan-Apr vs. May TOrC percent removal differences 
Biodegradability TOrCs Control BAF Ammonia BAF Chloramine BAF 
High Acetaminophen - - - 
High Caffeine - - - 
High Ibuprofen 1.4 -1.7 -0.6 
High Naproxen -6.8 7.5 0.9 
Moderate Atenolol 1.3 5.2 40.6 
Moderate Trimethoprim -25.3 -12.7 -57.2 
Moderate Triclosan -45.1 -28.0 -42.9 
Moderate Gemfibrozil -30.8 -64.6 -93.3 
Moderate DEET 11.4 9.5 12.9 
Low Meprobamate -2.8 2.5 11.3 
Low Sulfamethoxazole -10.3 -15.2 -7.5 
Low Fluoxetine -21.0 8.8 9.8 
Low Carbamazepine -10.0 0.9 13.4 
Low TCEP 14.5 26.2 28.0 
Low Sucralose (x100) -4.9 -5.9 10.2 
Low Primidone -2.3 11.8 23.1 
 
 
Despite the introduction of AOA and AOB inhibitors to the BAFs, the removals of highly 
biodegradable compounds ibuprofen and naproxen remained very similar to the average 
removals observed from January to April. In fact, the difference in percent removal for 
ibuprofen was negligible ranging from only 1.4% to -1.7% compared to previous months, which 
is well within the standard deviation. Removal of naproxen displayed a nearly negligible 
decrease in removal in the control BAF and nearly negligible increase in the ammonia dosed 
BAF, with practically no change in the chloramine dosed BAF. This is similar to a previous study 
by Rattier et al. (2014) which found no significant impact to ibuprofen and naproxen removal 
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with ATU addition, suggesting that these two compounds are removed by other 
microorganisms. It is unfortunate that acetaminophen and caffeine were below the MRL in the 
feed as they were both good indicators for AOM inhibition in a study conducted by Rattier et 
al., 2014, where acetaminophen and caffeine removal was significantly limited by addition of 
ATU.  
From the moderately biodegradable TOrCs, atenolol removal actually increased (40%) in the 
chloramine dosed BAF as did DEET in the control (11.5%), ammonia dosed (99.5%), and 
chloramine dosed (13%) BAFs. However, two other moderately biodegradable TOrCs, 
trimethoprim and triclosan displayed decreases in removal across the control (25% and 45%, 
respectively), ammonia dosed (13% and 28%, respectively), and chloramine dosed (57% and 
43%, respectively) BAFs. Gemfibrozil, which is considered moderately biodegradable exhibited 
removal decreases across the control (-31% decrease), ammonia dosed (-65% decrease), and 
chloramine dosed (-93% decrease) BAFs. A previous study conducted by Rattier et al. (2014) 
found that gemfibrozil removal was negatively impacted by ATU removal so it is likely that this 
increase in effluent concentration was a result of decreased AOM cometabolic activity due to 
inhibition.  
Some significant differences were seen for the low biodegradability compounds besides an 
increase in TCEP removal of 14.5%, 26%, and 28% for the control, ammonia dosed, and 
chloramine dosed BAFs, respectively. A decrease in fluoxetine removal of 21% in the control 
BAF and increased removal of primidone of 23% in the chloraminated BAF and 12% in the 
ammonia BAF were also observed. A decrease of 15% sulfamethoxazole removal in the 
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ammonia dosed column was also observed. The increase in TCEP removal is somewhat 
surprising as well as the significant decrease in fluoxetine removal which was thought to be 
removed through GAC adsorption. Such a consistent increase in TCEP removal may be 
indicative of a competitive relationship between AOMs and another microorganism capable to 
degrading TCEP. Additionally, fluoxetine removal may be facilitated by AOBs and AOAs rather 
than GAC adsorption, but it is difficult to say in this case due to the decrease occurring only in 
the control BAF.  
In summary, the highly biodegradable TOrCs (ibuprofen and naproxen) and the low 
biodegradability TOrCs experienced minor to no changes when AOM inhibitors were added to 
the BAFs. However, it is within the moderately biodegradable TOrCs that the impacts can be 
seen. This makes sense considering that highly biodegradable compounds are likely to still be 
removed by other substrate promiscuous microorganisms while AOMs play a larger and more 
specific role in the removal of the moderately biodegradable TOrCs. It was difficult to draw any 
meaningful conclusions about the low biodegradability TOrCs because they displayed typically 
negligible removal differences or varied a lot. Overall, expect for TCEP (14-22%), primidone 
(23%, in the chloramine dosed BAF only), and atenolol (41%, only in the chloramine dosed BAF), 
the inhibitors decreased or did not substantially affect removal. It should also be noted that the 
impacts of ATU and PTIO on Comammox are still not fully understood meaning that they might 





In order to verify that biological activity was occurring and being retained in the BAFs, the total 
ATP measurements were conducted weekly from January to May 2021 on secondary effluent, 
ozonated secondary effluent, the effluents of the three BAFs, and a backwash composite 
sample to determine the presence of biological activity. Secondary effluent had a high total ATP 
with an average of 2,176 + 901 RLU which is likely an underestimate as the ATP kit used does 
not lyse cells efficiently. Surprisingly, ozonated secondary effluent had similar or even 
sometimes higher total ATP than non-ozonated secondary effluent with an average of 1,975 + 
847 RLU. It is possible that the ozone may actually help lyse the cells and release more ATP 
rather than destroying it. The control, ammonia dosed and chloramine dosed BAFs displayed 
similar total ATP with averages of 173 + 68 RLU, 196 + 52 RLU, and 197 + 105 RLU, respectively. 
The backwash composite sample displayed by far the highest total ATP with an average of 7,712 
+ 1,988 RLU.  
 
The ozonated effluent ATP was initially intended to provide a control or “zero” to compare the 
BAF effluent data against; however, the total ATP measurement does not account for live or 
dead cells so although live ATP is presumably low following ozonation, the total ATP remains 
high. Additionally, the high suspended solids present in the secondary effluent may provide 
some protection from ozonation. Therefore, the ozonated effluent ATP could not be used as a 
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proper control group for the secondary and BAF effluent ATPs. The ATP removals were over 
90% for the control, ammonia dosed, and chloramine dosed BAFs. The backwash composite 
ATP levels were consistently 3.5 times higher than secondary effluent on average. These high 
reductions of ATP by all the BAFs and high concentrations of ATP present in the backwash show 
that biomass is not just passing through the columns but is being retained in and growing 
within the BAFs effectively. Additionally, ATP levels following inhibition exhibited no substantial 




The qPCR results for AOB, AOA, and Comammox were normalized by dividing the gene copy 
concentrations (gc/L water or gc/g media) by their respective 16S rRNA gene copy numbers to 
provide a relative abundance that is suitable for comparison purposes. The use of these 
comparisons assumes that the biofilm was consistent throughout the columns which is 
supported by the consistent ATP levels in the column effluents.  
4.5.2.1 16S rRNA 
To get an idea about the general microbial quantity in the pilot, the first qPCR assay was for the 
16S rRNA gene which was conducted on effluent and suspended solids from effluent samples 
from January to April 2021, and on media samples from January to May of 2021. The 16S rRNA 
gene assay provides a general total measure for the microbial quantity in the secondary 
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effluent, BAF effluents, suspended solids in the BAF effluents, and media samples. The average 
16S rRNA gene concentrations are shown in Table 10, measured in gene copies per liter of 
water (gc/L water) for effluent and suspended solids samples, and gene copies per gram of 
media (gc/g media) for media samples. Complete 16S rRNA gene concentration data are 
provided in Appendix C. 
 
 
Table 10: Average 16S rRNA gene concentrations of effluent and suspended solids in effluent from January to April, 2021; and 
BAF media from January to May, 2021 
16S rRNA gene (gc/L water or gc/g media) Average Standard deviation 
Secondary effluent 1.35E+10 2.08E+09 
Control BAF effluent 3.38E+08 1.53E+07 
Ammonia BAF effluent 4.46E+08 6.10E+07 
Chloramine BAF effluent 3.75E+08 1.08E+08 
Suspended solids in control BAF effluent 2.46E+08 8.53E+07 
Suspended solids in ammonia BAF effluent 5.00E+08 2.00E+08 
Suspended solids in chloramine BAF effluent 2.27E+08 9.26E+07 
Control BAF media top 1.24E+09 8.08E+08 
Control BAF media bottom 6.02E+09 1.07E+10 
Ammonia BAF media top 6.10E+08 3.89E+08 
Ammonia BAF media bottom 7.04E+08 2.70E+08 
Chloramine BAF media top 5.23E+08 3.54E+08 
Chloramine BAF media bottom 1.18E+09 6.91E+08 
 
 
The 16S rRNA gene concentrations from January to April 2021 for the effluent, suspended 
solids, and media samples are presented in Figures 10, 11, and 12, respectively.  
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Figure 10: Effluent 16S rRNA gene copy numbers per liter of water from January to April, 2021 
 
 
Figure 10 shows that the 16S rRNA gene present in the secondary effluent (1010 gc/L water) was 
around two orders of magnitude greater than the 16S rRNA gene present in the effluent of the 
control, ammonia dosed, and chloramine dosed BAFs (108 gc/L water). This large difference in 
microbial abundance provides validation that the majority of the abundance was retained 
within the BAFs. The ammonia dosed BAF effluent had the highest 16S rRNA gene throughout 
the entire study with the exception of January while the control BAF effluent had the lowest 
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the lowest. Still, overall the three BAFs exhibited similar effluent 16S rRNA gene concentrations 




Figure 11: Suspended solids 16S rRNA gene copy numbers per liter of water from January to April, 2021 
 
 
The suspended solids 16S rRNA gene assay concentrations were similar to the effluent 
concentrations around 108 gc/L water, suggesting that the majority of microbial cells in the 
































Control BAF Ammonia BAF Chloramine BAF
70 
contained in the suspended solids from all the BAFs was still two orders of magnitude lower 
than the 16S rRNA gene in the secondary effluent water samples which again confirms that 
microbial abundance is retained within all three BAFs. While all three BAFs exhibited similar 16S 
rRNA gene concentrations throughout the study, the ammonia dosed BAF had the highest 16S 
rRNA gene concentrations throughout the entire study with the exception of January. The 
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As presented in Figure 12, the 16S rRNA gene concentrations observed on the media samples 
were of similar order of magnitude (108 gc) or even a bit higher (109 gc) than the effluent and 
suspended solids samples meaning that the total 16S rRNA gene in one liter of BAF effluent is 
similar to or less than the 16S rRNA gene contained on one gram of media, due to biofilm 
formation and its dense nature. Interestingly, a steady decrease in 16S rRNA gene was generally 
seen throughout the study for all three BAFs with January having the highest concentrations. 
This may be due to a change in DNA extraction procedure for the March and April samples 
where only one extraction was performed as opposed to three extractions on January and 
February samples. This extraction change was made in order to save time and resources and 
was deemed appropriate as gel electrophoresis and Qubit quantification showed that the 
quality and amount of DNA extracted after only one extraction was suitable for qPCR analysis 
especially since AOM abundances are normalized. This 16S rRNA gene assay provides a solid 
baseline to normalize AOM results. 
For the control BAF, the top sampling point had more microbial abundance. On the contrary, 
for the ammonia and chloramine dosed BAFs, the bottom sampling point typically exhibited 
higher 16S rRNA gene concentrations. This is intuitive as monochloramine is known to have 
inhibitory impacts on microbial communities. Therefore, the top sampling point will experience 
more inhibition but in the lower sampling point the concentrations of monochloramine is 
reduced. It is unclear why less microbial abundance was observed at the top sampling point of 
the ammonia dosed BAF. 
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For the May 2021 sampling event, the highest concentrations of 16S rRNA gene for nearly every 
sampling point were observed with the exception of the chloramine dosed BAF bottom 
sampling point (Table 11). Particularly, the bottom control BAF sampling point recorded 16S 
rRNA gene concentration an order of magnitude higher than any other media samples. This is 
likely a result of warmer water temperatures experienced in May compared to the previous 
months as seen in Table 6, which promotes microbial development. 
 
 
Table 11: May 2021 16S rRNA gene concentrations in media 
5/18/2021 16S rRNA gene in media 
Sample location gc/g media 
Chloramine BAF bottom 1.87E+09 
Chloramine BAF top 1.02E+09 
Ammonia BAF bottom 1.12E+09 
Ammonia BAF top 1.20E+09 
Control BAF bottom 2.74E+10 




The second qPCR assay was for AOBs which are typically expected to be present in high 
abundance since the secondary effluent is nitrified. Again, effluent (secondary effluent, control 
BAF, ammonia BAF, chloramine BAF) and suspended solids from filtered effluent (control BAF, 
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ammonia BAF, chloramine BAF) samples were collected for January to April 2021 while media 
samples from two depths were collected for each of the three BAFs from January to May 2021. 
In order to correct for any error or difference in DNA extraction, the abundance of AOBs 
detected was normalized with the 16S rRNA results to provide a relative abundance of AOBs. 
The average relative abundance of AOBs compared to 16S rRNA (Table 12). Complete AOB 
concentration data are available in Appendix C. 
 
 
Table 12: Average relative abundance of AOBs in effluents and suspended solids from January to April, 2021; and media from 
January to May 2021 
Sample type 
Relative AOB abundance (%) 
Average Standard deviation 
Secondary effluent 1.94E-03 1.29E-03 
Control BAF effluent <LOQ <LOQ 
Ammonia BAF effluent <LOQ <LOQ 
Chloramine BAF effluent <LOQ <LOQ 
Suspended solids in control BAF effluent 0.228 0.103 
Suspended solids in ammonia BAF effluent 0.453 0.254 
Suspended solids in chloramine BAF effluent 0.180 0.112 
Control BAF media top 0.417 0.146 
Control BAF media bottom 0.392 0.267 
Ammonia BAF media top 1.645 0.212 
Ammonia BAF media bottom 0.524 0.163 
Chloramine BAF media top 0.943 0.387 
Chloramine BAF media bottom 0.390 0.118 
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The effluent samples were ineffective in providing a good picture of AOB abundance with only 
the secondary effluent sample above the limit of quantification (LOQ) and even still, very 
limited. The suspended solids samples were able to better capture the AOB genes and the 
media samples contained the highest number of AOB gene copies. The differences can be 
better viewed with relative AOB abundance in the effluent, suspended solids, and media 
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The effluent assays for all three BAF either failed QA/QC or were well below the LOQ (Figure 
13). This is due to the effluent analysis being conducted on a very small effluent sample volume 
compared to the filtered and media samples resulting in many effluent values being below LOQ. 
The AOB abundance in the secondary effluent increased from January to April in the range of 
<0.001% water to >0.004%. This abundance increase of AOBs might be attributed to 
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For the suspended solids samples, the AOB abundance of the ammonia dosed BAF was 
significantly higher than those of the control and chloramine dosed BAFs for January through 
March (Figure 14). While AOB abundance remained near the range of 0.1% to 0.25% in the 
control and chloramine dosed BAF, the ammonia dosed BAF had AOB abundance as high as 
almost 0.9% in March and around 0.4% in January and February. The decrease in AOB 
abundance is April is strange especially after the large increase in March. It could be due to the 
ammonia dosed column cracking and losing some media near the inlet (where AOB were most 
abundant) a little over a week before the April sampling day. In general, the AOBs prefer higher 
ammonia environments (Limpiyakorn et al., 2011; Roy et al., 2017; Sauder et al., 2012) which is 




Figure 15: Relative abundance of AOB in media samples from January to May, 2021 
 
 
For the media samples, over time the AOB abundance stayed fairly consistent despite a few 
outliers (Figure 15). For the most part, the relative AOB abundance in the control and 
chloramine dosed BAFs were very similar month to month with a few exceptions. However, the 
ammonia dosed BAF displayed the highest relative AOB abundance in all cases with respect to 
the top sampling point and in the majority of cases with respect to the bottom sampling point. 
This distribution is similar to the suspended solids, validating that the ammonia dosed column 
provided the ideal conditions for AOB development out of the three BAFs. Additionally, the AOB 
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with top and bottom sampling point sharing similar AOB abundance during the majority of the 
study, while the AOB abundance of the top sampling point of the ammonia dosed BAF was on 
average around three times higher than that of the lower sampling point. The addition of AOB 
activity inhibitor ATU in May did not appear to have a substantial impact on the relative AOB 
abundance. This is intuitive considering that qPCR is a measurement of abundance and not AOB 
activity. Furthermore, the continuous addition of ATU over a longer period of time may have 
more substantial impact to AOB abundance as AOB may die off. 
 
4.5.2.3 AOA 
The third qPCR assay was for AOA and was performed for the same samples as the 16S rRNA 
and AOB assays and the results were normalized by the same method as the AOB assay. The 
average relative abundance of AOAs is presented in Table 13. Complete AOA concentration 







Table 13: Average relative abundance of AOAs in effluents and suspended solids from January to April, 2021; and media from 
January to May, 2021 
Sample Type 
Relative AOA abundance (%) 
Average Standard deviation 
Secondary effluent 4.47E-04 3.62E-04 
Control BAF effluent 1.146 <LOQ 
Ammonia BAF effluent 1.299 0.381 
Chloramine BAF effluent 1.774 0.880 
Suspended solids in control BAF effluent 0.029 0.008 
Suspended solids in ammonia BAF effluent 0.017 0.007 
Suspended solids in chloramine BAF effluent 0.018 0.002 
Control BAF media top 0.085 0.038 
Control BAF media bottom 0.100 0.081 
Ammonia BAF media top 0.081 0.036 
Ammonia BAF media bottom 0.127 0.050 
Chloramine BAF media top 0.099 0.010 
Chloramine BAF media bottom 0.082 0.032 
 
 
The AOA abundance in the secondary effluent was much lower than the column effluents, 
similar to the AOBs; however, the relative abundances in the BAF effluents for AOAs were lower 
than those of the AOBs. In the BAF effluents, the AOAs were definitely present but were 
typically less abundant than the AOBs with many samples falling below the LOQ. The relative 
AOA abundance in the effluent, suspended solids, and media samples plotted over time are 
illustrated in Figures 16, 17, and 18, respectively.  
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Figure 16: Relative abundance of AOA in effluent samples from January to April, 2021 
  
 
For the BAF effluent, multiple samples for the control, ammonia dosed, and chloramine dosed 
BAFs failed QC or were below the LOQ (Figure 16). However, the average AOA abundance in all 
three BAF effluents (1% to 2.6%) were consistently three orders of magnitude higher than the 
secondary effluent (10-3 % to 10-5 %). This is a good sign that the abundance of AOAs in the 
BAFs is greater than the in the secondary effluent meaning that AOAs are being retained and 
are likely abundant within the BAFs. For both secondary effluent and BAF effluent, the AOA 
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Figure 17: Relative abundance of AOA in suspended solids samples from January to April, 2021 
 
 
Some suspended solids samples also failed QC or were below the LOQ (Figure 17). Surprisingly, 
the suspended solids samples displayed less relative abundance than the effluent samples 
which indicates that the AOA tend to remain in the bulk water phase rather than the suspended 
solids. The AOA abundance in the control and ammonia BAFs effluent suspended solids steadily 
decreased over time whereas the chloraminated BAF had slightly increased AOAs from January 
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Figure 18: Relative abundance of AOA in media samples from January to May, 2021 
 
 
As presented in Figure 18, some media samples experienced similar issues as the effluent and 
suspended solids samples and failed QC or were below the LOQ. The relative abundance of 
AOAs in the media samples were greater than the AOA abundance in the effluent samples but 
below the abundance in the BAF effluent suspended solids samples. The AOA abundance 
peaked in February for the majority of sampling points but otherwise stayed fairly consistent 
with a few outliers. The abundance of AOA were also typically higher in the bottom sampling 
point for each BAF which is intuitive given the AOA preference for low ammonia and DO 
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substantial impact on the relative AOA abundance. This is intuitive considering that qPCR is a 
measurement of abundance and not AOA activity. Furthermore, the continuous addition of 
PTIO over a longer period of time may have more substantial impact to AOA abundance as AOA 
may die off. 
 
4.5.2.4 Comammox 
The final qPCR assay was for Comammox which were found in high abundance in some WWTPs 
(Roots et al., 2019; M. Wang et al., 2018) but not found at all in others (Cotto et al., 2020). The 
Comammox were found to be abundant in effluent, suspended solids from filtered effluent, and 
media samples. The average relative abundance of Comammox compared to 16S rRNA is listed 








Table 14: Average relative abundance of Comammox in effluents and suspended solids from January to April 2021; and media 
from January to May, 2021 
Sample Type  
Relative COM abundance (%) 
Average Standard deviation 
Secondary effluent 2.89E-03 7.70E-04 
Control BAF effluent 0.601 0.081 
Ammonia BAF effluent 0.686 0.109 
Chloramine BAF effluent 0.983 0.186 
Suspended solids in control BAF effluent 0.345 0.060 
Suspended solids in ammonia BAF effluent 0.182 0.030 
Suspended solids in chloramine BAF effluent 0.435 0.256 
Control BAF media top 2.794 1.131 
Control BAF media bottom 0.520 0.398 
Ammonia BAF media top 0.560 0.090 
Ammonia BAF media bottom 0.270 0.147 
Chloramine BAF media top 3.690 1.675 
Chloramine BAF media bottom 1.264 0.772 
 
 
The average relative Comammox abundance in the secondary effluent was higher than the AOB 
and AOA assays but the BAF effluents are lower than AOAs. In the suspended solids and media 
samples, Comammox were more or similarly abundant compared to AOB and AOA. The relative 
Comammox abundance in the effluent, suspended solids, and media samples plotted over time 




Figure 19: Relative abundance of COM in effluent water samples from January to April 2021 
 
 
The January and February chloraminated BAF effluent failed QC or were below the LOQ (Figure 
19). Despite this, the chloraminated BAF had the highest Comammox abundance for the March 
and April samples. The ammonia dosed BAF had the second highest Comammox abundance in 
all events except for March and the control BAF contained relatively the least Comammox. All 
three BAFs had similar Comammox abundance between 0.55% to 0.8% with the exception of 
the chloramine BAF in March. The BAF effluents contained substantially more relative 
Comammox abundance than the secondary effluent. This is a good indicator of Comammox 
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Figure 20: Relative abundance of COM in suspended solids samples from January to April 2021 
 
 
Figure 20 shows that the suspended solids samples exhibited similar or lower Comammox 
abundance to the secondary effluent at around 0.15% to 0.4% with the chloraminated BAF 
having occasionally higher Comammox abundance around 0.6 to 0.8%. The ammonia dosed BAF 
typically contained the least Comammox while the Comammox abundance in the control BAF 
remained consistent, and the Comammox abundance in the chloraminated BAF varied month 
to month. In general, the Comammox was more abundant during February and March and less 
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Figure 21: Relative abundance of COM in media samples from January to May 2021 
 
 
Similar to the suspended solids assay, the control BAF top sampling point contained high 
relative abundance of Comammox and the ammonia dosed BAF contained relatively minimal 
Comammox abundance (Figure 21). The chloraminated BAF top sampling point typically 
contained relatively the highest amount while the lower sampling point varied. Overall, the 
abundance of Comammox on the media were significantly higher than the abundance observed 
in both the effluent and suspended solids assays. Also, the larger relative abundance of 
Comammox were observed in the top sampling point in all cases which is the opposite of the 
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environments than AOBs and AOAs. The addition of AOB and AOA inhibitors ATU and PTIO did 
not appear to impact the relative Comammox abundances which makes sense given that the 
impact of ATU and PTIO on Comammox are unknown. Furthermore, qPCR measure abundance 
and not activity and the inhibitors were not dosed continuously for long enough to cause die 
off. 
 
4.5.1.5 Nitrifying Community Overview 
The overall nitrifying community contained three groups of AOMs that were analyzed by qPCR 
for secondary effluent, BAF effluent, and BAF media samples. Although some community 
changes occurred over the five-month sampling period, the AOM distribution remained fairly 
consistent. When compared to the 16S rRNA assay the AOM communities only made up a very 
small percent of the microbial population in the highest case (<5%) and were often <3% 
compared to 16S rRNA which is common for secondary treatment processes of WWTPs (Harms 
et al., 2003). The average percent of AOMs relative to 16S rRNA from the four assays is 




Figure 22: Average percent of AOMs relative to 16S rRNA 
 
 
Although the abundance of AOM seems minimal compared to 16s rRNA, it is more important to 
compare the relative abundances of AOA, AOB, and Comammox assays in order to draw 
conclusions about AOM dominance. The average abundance from the AOA, AOB, and 
Comammox assays for each sampling point was plotted in Figure 23 by percentage to give a 
















































Figure 23: Average AOM abundances by percent of AOM community 
 
 
For the effluent samples, Comammox dominated the secondary effluent, followed by AOBs 
with AOAs making up the smallest fraction of the community. The BAF effluents appear to be 
dominated mainly by AOAs that make up about three quarters of the population. However, this 
is misleading as AOB populations are misrepresented due to samples either being below the 
LOQ or failing QC. The suspended solids assay shows that the Comammox clearly dominated 
the control and chloraminated BAFs followed by AOBs. However, the AOBs dominated the 
ammonia dosed BAF with Comammox making up the majority of the remaining population. 
































the AOBs dominated the ammonia dosed BAF at both depths. The AOAs also made up a small 
percentage of all the media samples but were most abundant in the bottom sampling points for 
the control and ammonia dosed BAF. 
Overall, it appears that the addition of ammonia promoted the development of AOBs rather 
than Comammox, which dominated the control BAF. The addition of chloramine promoted the 
development of an AOM profile that is very similar to the control near the influent of both 
BAFs. However, the chloraminated BAF maintained a consistent AOM profile throughout its 
depth while the control BAF displayed a shift to a relative decrease in Comammox and increase 
in AOB abundance. This higher Comammox abundance at the lower depth of the chloramine 
column may be due to the utilization of the ammonia present from chloramine decomposition 
at a greater depth within the BAF. 
In summary, the dominance of AOB in the ammonia dosed column corresponded to a higher 
ammonia environment that achieved nitrification but was outperformed in the removal of all 
TOrCs by the control and the majority of TOrCs by the chloramine dosed column. However, the 
dominance and higher relative abundance of Comammox throughout the depth of the 
chloramine dosed column corresponded to a lower ammonia environment that was able to 
outperform the control in high biodegradability TOrC removal but underperformed in the 
majority of moderate and low biodegradability TOrCs. The chloramine dosed BAF was more 
similar to the control in terms of nitrogen concentrations, TOrC removal, and relative AOM 
abundances and outperformed the ammonia dosed column in overall TOrC attenuation.    
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Chapter 5: Conclusions and Recommendations for Future Work 
5.1 Conclusions 
In this study, the impacts of ammonia and chloramine dosing into columns containing BAC to 
examine differences in TOrC degradation, and the relative abundances of AOA, AOB, and 
Comammox within the system were investigated.  A control BAF which was fed secondary 
effluent containing very limited concentrations of ammonia and nitrite served as a baseline for 
typical operation without any significant nitrification of denitrification. An ammonia dosed BAF 
was fed secondary effluent with a supplemental dose of 2 mg N/L of ammonia and performed 
nitrification. A chloramine dosed BAF was fed secondary effluent with a dose of 0.3 mg Cl2/L of 
monochloramines and similar to the control, did not perform any significant nitrification or 
denitrification. To provide additional verification of AOM biodegradation of TOrCs, two AOM 
specific inhibitors ATU and PTIO were dosed at a high concentration prior to the final sampling 
event to compare TOrC removal differences. 
Interestingly, the chloramine dosed BAF outperformed the control in the removal of highly 
biodegradable TOrCs but exhibited little benefit in terms of moderate and low biodegradability 
TOrCs. The ammonia dosed BAF on the other hand performed significantly worse than the 
control in the removal of all TOrCs and worse than the chloramine dosed BAF in the majority of 
cases. Additionally, the impact of AOM inhibitors was not significant for highly biodegradable 
TOrCs, but worse removals were observed for moderately biodegradable TOrCs which is 
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intuitive considering that other microorganisms are capable to removal of highly biodegradable 
compounds. 
The microbial profile of the secondary effluent contained a majority of Comammox with a 
strong AOB presence and limited AOA presence. The effluent water and media from the control 
and chloramine dosed columns were dominated by Comammox while the ammonia dosed 
column was dominated by AOB. The control column was dominated by Comammox at the top 
sampling point the bottom sampling point displayed higher abundance of AOBs. The 
chloraminated column on the other hand was consistent in relative Comammox and AOB 
abundance throughout its depth. The ammonia dosed column exhibited similar relative 
Comammox and AOB abundance throughout the depth, but AOA abundance was higher in the 
lower sampling depth. 
Based on these findings, the addition of ammonia to the BAF system developed a nitrifying, 
primarily AOB dominated community that performed worse degradation of all analyzed TOrCs 
than the control. The addition of chloramine into the BAF system on the other hand developed 
a primarily Comammox dominated community that did not provide significant nitrification or 
denitrification, that was able to degrade highly biodegradable TOrCs more effectively than the 
control and ammonia dosed columns, but was unable to provide significant improvement in low 
and moderately biodegradable TOrCs compared to the control. The overall TOrC removals 
reported from all BAFs in this study are still not a significant improvement or even performed 
worse removal of some TOrCs compared to previous BAF studies (Greenstein et al., 2018; 
Rattier et al., 2014) leaving the need for future research on BAF optimization. 
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The first hypothesis that additional ammonia increases AOB development and provides better 
TOrC attenuation was found to be partially true as the ammonia dosed column did display an 
increased relative abundance of AOB but performed worse than the control and chloramine 
dosed columns in TOrC reduction. Additionally, although the relative AOB abundance increased, 
the combined relative AOM abundance was actually less than the control and chloramine dosed 
BAFs which both had far higher Comammox abundances. The second hypothesis was partially 
true as the addition of chloramine did increase highly biodegradable TOrC removal but not 
moderate and low biodegradability TOrC removal. Comammox were more abundant in the 
bottom depth than the control; however, all AOMs were actually relatively more abundant or 
unchanged in the top depth of the media compared to the control and ammonia dosed 
columns. The third hypothesis was also partially true as Comammox dominated the control and 
chloraminated BAFs, but not the ammonia BAF which was AOB dominated. The nature of this 
study makes it difficult to draw concrete conclusions on which AOM provides the best TOrC 
removal; however, the Comammox dominated the control and chloraminated columns which 
performed the best TOrC removal indicating that Comammox likely provide the best TOrC 
attenuation. This study shows that the addition or even presence of excess ammonia into a 
wastewater BAF system actually decreases TOrC removal while the addition of a low dose of 
chloramine into a BAF system may be beneficial for biological removal of certain TOrCs. 
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5.2 Recommendations for Future Work 
Although this thesis research provided some insight into the impacts of ammonia and 
chloramine dosing on TOrC removal and AOM abundance in BAF systems, it revealed several 
knowledge gaps that are recommended for future work.  
• Sequencing to better understand the microbial community, particularly to understand 
which species of AOMs are present so that we may better understand the impacts of 
ammonia and chloramine dosing on specific species.  
• Future experiments into the impacts of higher chloramine doses should be conducted as 
the dose chosen in this study was quite low. Since the low dose of monochloramine 
improved highly biodegradable TOrC removal perhaps a higher dose (but not too high 
where significant microbial inhibition is occurring) would further the microbial 
community changes and hopefully provide higher TOrC reductions.  
• The impact of inhibitors ATU and PTIO on Comammox should be further studied as well 
as other potential Comammox specific inhibitors so that differences between TOrC 
removal by inhibited Comammox populations can be compared to uninhibited 
operation. 
• The impacts of prolonged and continuous use of inhibitors ATU and PTIO should be 
further studied as the short inhibition period used did not provide substantial AOM 
abundance or TOrC removal differences. Additionally, the use of ATU and PTIO 
separately could help clarify the roles of AOA and AOB to TOrC removal, respectively. 
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• To provide a better big picture of the column conditions, DO and total organic carbon 
(TOC) measurements should be conducted in future research to assess redox conditions 
and changes in TOC. 
• Batch kinetics experiments to gain insight into biodegradation rates of certain TOrCs by 
the column media should be conducted. 
• Given the common practice of combining BAF treatment with ozone pretreatment, it 
would also be interesting to evaluate the impacts of ammonia and chloramine dosing in 
a BAF system on TOrC attenuation with ozone pretreatment. The microbial community 
may change due to oxidation by ozone as well as higher availability of oxygen, ammonia 
and other nutrients/chemicals including some TOrCs would also be oxidized following 
ozone, and chloramine demand would be lower. Additionally, ozonation would form 
disinfection by-products which are another unique challenge to water reuse so it would 
be interesting to see if AOMs are able to reduce disinfection by-products as well. 
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Appendix A: TOrC Removal in Biofiltration Review  




Removal (%) EBCT (min) 
n Ref. 
Med Min Max Med Min Max 
1,2-Dichlorobenzene Inert 72 63 83 4 4 4 6 36 
1,4-Dichlorobenzene Inert 71 61 79 4 4 4 6 36 
1,7-Dimethylxanthine Inert 0 0 0 20 20 20 1 35 
1,7-Dimethylxanthine GAC 94 45 99 21 20 30 2 7 
10,11-Dihydro-10,11-
dihydroxy-carbamazepine 
GAC 46 0 92 32 32 32 2 32 
10,11-Dihydro-10,11-
dihydroxy-carbamazepine 
Inert 0 0 0 59 29 90 3 22, 32 
10-Hydroxy-carbamazepine Inert 50 30 70 90 90 90 1 22 
17β-Estradiol Inert 80 5 95 11 11 11 2 7, 39 
2,3,4-Trichlorophenol Inert 1 1 1 4 4 4 3 36 
2,4,6-Trichlorophenol Inert 1 1 1 4 4 4 3 36 
2,4-Dichlorophenol Inert 28 23 30 4 4 4 3 36 
2,4-Dichlorophenoxyacetic 
Acid 
GAC 70 70 70 18 18 18 1 46 
2,4-Dichlorophenoxyacetic 
Acid 
Inert 71 43 77 12 8 16 3 5, 61 
2,6-Dichlorophenol Inert 24 21 28 4 4 4 3 36 
2-Hydroxy ibuprofen GAC 38 38 38 32 32 32 1 32 
2-Hydroxy ibuprofen Inert 38 38 38 29 29 29 1 32 
2-Hydroxy-carbamazepine Inert 0 0 0 90 90 90 1 22 
3-desmethyl-trimethoprim Inert 10 -10 30 90 90 90 1 22 
3-Hydroxy-carbamazepine Inert 0 0 0 90 90 90 1 22 
4-amino-6-chloro-1,3-
benzenedisulfonamide 
Inert 0 0 0 90 90 90 1 22 
4-Hydroxy-Diclofenac Inert 10 -10 30 90 90 90 1 22 
4-Nonylphenol Inert 0 0 0 20 20 20 1 35 
4-tert-Octylphenol Inert 9 0 17 20 20 20 1 5, 35 
5-Fluorouracil Inert 97 97 98 NA NA NA 1 42 
9-Carboxylic acid-Acridine Inert 0 -10 10 90 90 90 1 22 
Acesulfame K Inert 50 -163 70 52 14 90 3 
5, 16, 
22 










Acetochlor Inert 13 8 17 11 8 16 2 61 
Acetyl-Sulfamethoxazole Inert 50 30 70 90 90 90 1 22 
Aciclovir Inert 40 20 60 90 90 90 1 22 
Acridone Inert -10 -20 0 90 90 90 1 22 
Albuterol Inert 43 0 85 17 14 20 1 16, 35 
Aldicarb Inert 61 49 72 12 8 15 2 61 
Alfuzosin GAC 84 84 84 NA NA NA 1 3 
Aliksiren Inert 0 -30 30 90 90 90 1 22 
Aminotriazole Inert 50 0 100 14 10 18 2 62 
Amisulpride Inert 0 0 0 90 90 90 1 22 
Amoxicillin Inert 21 0 42 17 14 20 1 16, 35 
Androstenedione GAC 97 97 97 2 2 2 1 48 
Androstenedione Inert 41 41 41 2 2 2 1 48 
Antipyrine Inert 21 21 21 23 23 23 1 51 
Antipyrine GAC 100 100 100 23 23 23 1 51 
Atenolol GAC 94 75 98 21 9 30 3 
3, 15, 
46, 51 







Atenolol acid Inert 20 20 20 90 90 90 1 22 
Atorvastatin GAC 100 100 100 30 30 30 1 15 
Atrazine GAC 48 -20 83 8 2 30 6 
6, 15, 
33, 48 
Atrazine Inert 10 0 99 16 2 30 11 





Atrazine-Desethyl Inert 8 8 8 7 7 7 1 27 
Atrazine-Hydroxy Inert 15 15 15 7 7 7 1 27 
Azithromycin Inert 98 98 98 23 23 23 1 51 
Azithromycin GAC 100 100 100 23 23 23 1 51 
Azoxystrobin Inert 98 98 98 16 16 16 1 8 
99 
Benzo[a]pyrene GAC 89 89 89 2 2 2 1 49 
Benzo[a]pyrene Inert 89 89 89 2 2 2 1 49 
Benzophenone GAC 51 51 51 30 30 30 1 15 
Benzotriazole GAC 95 93 96 32 32 32 1 32 
Benzotriazole Inert 24 19 40 7 7 90 3 
22, 27, 
32 
Bezafibrate GAC 100 100 100 23 23 23 1 51 
Bezafibrate Inert 40 20 100 23 7 90 3 
22, 27, 
51 
BHA GAC 99 99 99 30 30 30 1 15 
Bicalutamide Inert 0 0 0 90 90 90 1 22 
Biosol Inert 18 4 28 NA NA NA 1 42 
Biphenylol Inert 99 99 100 NA NA NA 1 42 
Bisoprolol GAC 88 82 95 NA NA NA 1 3 
Bisphenol A GAC 37 7 66 30 30 30 2 15, 23 




Bromacil Inert 0 0 0 20 20 20 1 35 
Bromochloroacetic Acid GAC 0 0 0 18 18 18 1 14 
Bromodichloromethane GAC 46 0 75 2 2 18 3 14, 54 
Bromophenol Inert 0 0 0 15 15 15 2 31 
Buprenorphine GAC 13 13 13 NA NA NA 1 3 
Bupropion Inert -5 -5 -5 6 6 6 1 40 
Bupropion GAC 77 77 77 NA NA NA 1 3 
Butalbital Inert 0 0 0 17 14 20 1 16, 35 





Caffeine Inert 81 -24 100 17 2 120 18 









Candesartan Inert 0 0 0 90 90 90 1 22 
Carbadox Inert 0 0 0 20 20 20 1 35 
100 




Carbamazepine Inert 5 0 99 17 2 120 21 








Carbaryl Inert 14 3 99 12 8 16 2 8, 61 
Carboxy-Aciclovir Inert 0 -10 10 90 90 90 1 22 
Carboxy-Diclofenac Inert -20 -30 -10 90 90 90 1 22 
Cetirizine Inert 0 0 0 90 90 90 1 22 
Chlorobenzene Inert 75 51 77 4 4 4 6 36 
Chlorophene Inert 99 99 99 NA NA NA 1 42 
Chlorothiazide Inert -10 -20 0 90 90 90 1 22 
Chlorpyrifos Inert 73 63 83 12 8 16 2 61 
Cimetidine Inert 17 0 97 18 16 20 3 
8, 35, 
52 
Citalopram GAC 91 50 97 14 9 18 2 3, 46 
Citalopram Inert 4 -11 10 8 6 90 4 
5, 22, 
40, 44 
Clarithromycin Inert 50 10 70 7 7 90 2 22, 27 
Clarithromycin GAC 71 56 86 NA NA NA 1 3 
Climbazole Inert 10 0 20 90 90 90 1 22 
Climbazole-OH Inert -110 -110 -110 90 90 90 1 22 
Clindamycine GAC 88 79 97 NA NA NA 1 3 
Clofibric Acid Inert 59 35 78 12 7 23 3 
27, 51, 
61 
Clofibric acid GAC 100 100 100 23 23 23 1 51 
Clopidogrel Inert 50 30 70 90 90 90 1 22 
Clopidogrel acid Inert 10 0 20 90 90 90 1 22 
Codeine GAC 85 85 85 NA NA NA 1 3 
COFA GAC 15 15 15 32 32 32 1 32 
COFA Inert 19 19 19 29 29 29 1 32 
Cotinine GAC 64 64 64 23 23 23 1 51 




Cyanizine Inert 0 0 0 14 14 14 1 16 
101 
DACT Inert 0 0 0 20 20 20 1 35 
DDT GAC 85 85 85 2 2 2 1 49 
DDT Inert 94 94 94 2 2 2 1 49 
DEET GAC 90 80 93 20 2 30 3 
15, 49, 
51 







Deethylatrazine GAC 0 -4 3 8 7 9 2 33 
Dehydronifedipine Inert 8 0 15 17 14 20 1 16, 35 
Deisopropylatrazine GAC 4 0 8 8 7 9 2 33 
Denatonium Inert 0 -10 10 90 90 90 1 22 
Desethyl Atrazine Inert -5 -5 -5 NA NA NA 1 5 
Desisopropyl Atrazine Inert 8 8 8 NA NA NA 1 5 
Desmethyl Citalopram Inert 3 -10 17 90 90 90 1 5, 22 
Diatrizoate GAC 27 25 29 32 32 32 1 32 
Diatrizoate Inert 15 5 21 18 7 29 3 
5, 27, 
32 
Diatrizoic acid Inert 0 -10 10 90 90 90 1 22 
Diazepam GAC 93 84 100 20 2 30 3 
15, 49, 
51 
Diazepam Inert 19 7 71 13 2 23 3 
49, 51, 
52 
Diazinon GAC 90 90 90 18 18 18 1 46 
Diazinon Inert 53 4 98 12 7 16 4 
8, 27, 
44, 61 
Dibromochloromethane GAC 0 0 0 18 18 18 1 14 
Dicamba Inert -25 -25 -25 NA NA NA 1 5 
Dichloroacetic Acid GAC 63 0 98 8 5 20 8 14, 57 










Diclofenac Lactam Inert -30 -30 -30 90 90 90 1 22 
Dilantin Inert 9 9 9 23 23 23 1 51 
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Dilantin GAC 98 98 98 23 23 23 1 51 
Diltiazem Inert 79 57 100 19 14 23 2 16, 51 
Diltiazem GAC 59 13 100 23 23 23 2 3, 51 
Dimethoate Inert 78 75 81 12 8 16 2 61 
Diphenhydramine GAC 53 53 53 NA NA NA 1 3 
Diphenhydramine Inert 98 10 99 53 16 90 3 
8, 22, 
52 
Diphenhydramine-N-oxide Inert -60 -60 -60 90 90 90 1 22 
Diuron GAC 66 32 99 14 9 18 2 46 




Doxylamine GAC 90 80 97 18 9 18 3 14, 46 
Doxylamine Inert 18 0 95 64 8 120 3 
5, 44, 
45 
EE2 (17α-Ethinylestradiol) Inert 54 29 71 NA NA NA 3 39 
Emtricitabine Inert 40 30 50 90 90 90 1 22 
Emtricitabine carboxylate Inert -20 -40 0 90 90 90 1 22 
Erythromycin GAC 55 38 78 14 2 32 2 
32, 46, 
49 





Estradiol GAC 58 43 94 16 2 30 3 
15, 18, 
49 
Estradiol Inert 95 1 100 10 2 18 3 49, 62 
Estradiol Equivalent GAC 98 98 98 30 30 30 1 15 
Estriol GAC 92 92 92 2 2 2 1 49 
Estriol Inert 37 1 92 2 2 2 2 39, 49 
Estrone GAC 87 64 95 16 2 30 2 
15, 18, 
49 
Estrone Inert 48 0 96 15 2 16 5 
8, 25, 
39, 49 
Ethinyl Estradiol GAC 67 43 91 2 2 2 1 18, 49 
Ethinyl Estradiol Inert 17 1 41 12 2 16 4 
25, 49, 
61 
Ethofumesate Inert 95 95 95 16 16 16 1 8 
Eythromycin Inert 59 28 90 120 120 120 1 45 
Fexofenadine GAC 83 73 93 NA NA NA 1 3 
Fexofenadine Inert 50 30 10 90 90 90 1 22 
Flecainide GAC 98 98 98 NA NA NA 1 3 
103 
Fluconazole GAC 95 94 95 NA NA NA 1 3 
Fluconazole Inert 0 0 0 90 90 90 1 22 
Fluorene GAC 98 98 98 2 2 2 1 49 
Fluorene Inert 28 28 28 2 2 2 1 49 
Fluoxetine GAC 99 99 100 20 2 30 3 
15, 49, 
51 
Fluoxetine Inert 97 50 99 14 2 23 3 
16, 49, 
51 
Formaldehyde GAC 84 68 92 10 5 20 3 10 
Formaldehyde Inert 70 66 74 10 5 20 3 10 
Furosemide GAC 10 10 10 18 18 18 1 46 
Furosemide Inert 25 0 97 20 8 120 2 
22, 35, 
44, 45 
Gabapentin GAC 29 21 37 32 32 32 1 32 




Gabapentin Lactam Inert -30 -30 -30 90 90 90 1 22 
Galaxolide GAC 76 74 79 2 2 2 1 23, 49 
Galaxolide Inert 16 -1 83 4 2 6 2 
5, 39, 
40, 49 
Gemfibrozil GAC 98 74 100 16 2 30 4 
15, 46, 
49, 51 

















Glyoxal GAC 78 58 93 10 5 20 3 10 
Glyoxal Inert 65 45 74 10 5 20 3 10 
Hydrochlorothiazide GAC 82 65 99 14 9 18 2 46 




Hydrocodone GAC 92 92 92 2 2 2 1 49 
Hydrocodone Inert 41 14 95 2 2 2 1 49, 52 
Hydroxyatrazine GAC 31 19 43 8 7 9 2 33 
Hydroxy-DEET Inert -20 -50 10 90 90 90 1 22 
Hydroxy-Metoprolol Inert 50 50 50 90 90 90 1 22 
Ibuprofen GAC 70 58 83 16 2 30 2 15 
Ibuprofen Inert 84 28 100 13 2 18 20 






Indomethacin Inert 25 25 25 8 8 8 1 44 
Iohexol Inert 24 -124 91 14 7 20 4 
9, 16, 
27, 35 
Iomeprol GAC 82 76 88 32 32 32 1 32 
Iomeprol Inert 24 15 93 29 7 90 4 
9, 22, 
27, 32 
Iopamidol Inert 7 7 7 7 7 7 1 27 
Iopromide GAC 88 42 94 17 2 32 1 32, 49 







Iopromide-TP-701A Inert -20 -40 0 90 90 90 1 22 
Iopromide-TP-701B Inert 0 0 0 90 90 90 1 22 
Iopromide-TP-729A Inert -10 -50 30 90 90 90 1 22 
Iopromide-TP-759 Inert -20 -60 20 90 90 90 1 22 
Iopromide-TP-819 Inert 0 -10 10 90 90 90 1 22 
Ioxitalamic acid Inert 34 34 34 7 7 7 1 27 
Irbesartan GAC 85 76 94 NA NA NA 1 3 
Irbesartan Inert 0 0 0 90 90 90 1 22 
Isobutylparaben Inert 0 0 0 14 14 14 1 16 
Isoproturon Inert 5 -10 99 53 16 90  8, 22 
Ketoprofen GAC 89 89 89 NA NA NA 1 3 
Ketoprofen Inert 78 0 99 14 8 20 4 
35, 39, 
42, 44 
Ketorolac Inert 0 0 0 17 14 20 1 16, 35 
Lamotrigine Inert 0 -10 10 90 90 90 1 22 
105 
Lidocaine Inert 0 -10 9 20 14 90 3 
16, 22, 
35 
Lincomycin GAC 100 100 100 23 23 23 1 51 
Lincomycin Inert 47 0 93 16 8 23 1 44, 51 
Lindane (γ-BHC) GAC 91 91 91 2 2 2 1 49 
Lindane (γ-BHC) Inert 7 7 7 2 2 2 1 49 
Linuron Inert -25 -50 0 17 14 20 1 16, 35 
Malaoxon Inert 33 16 49 12 8 16 2 61 
MCPA Inert 11 11 11 NA NA NA 1 5 
Meclofenamic Acid Inert 0 0 0 20 20 20 1 35 
Meclozine GAC 96 96 96 NA NA NA 1 3 
Mecoprop Inert 15 -33 46 8 7 90 4 
5, 21, 
22, 27 
Memantine GAC 62 36 88 NA NA NA 1 3 
Meprobamate GAC 43 11 81 15 2 30 6 
15, 33, 
49, 51 




Methomyl Inert 9 5 12 12 8 16 2 61 
Methyl glyoxal GAC 84 75 95 10 5 20 3 10 
Methyl glyoxal Inert 84 70 89 10 5 20 3 10 
Methylparaben Inert 31 27 35 NA NA NA 1 1 
Metolachlor GAC 0 0 79 7 2 9 3 33, 49 




Metoprolol GAC 95 65 99 14 9 18 2 3, 46 
Metoprolol Inert 9 -52 95 24 7 120 9 














Microcystin-LA GAC 70 50 100 15 15 15 5 55 
Microcystin-LA Inert 50 0 100 15 15 15 2 55 
106 
Microcystin-LR GAC 91 82 100 15 15 15 5 55 
Microcystin-LR Inert 54 8 100 15 15 15 2 55 
Mirtazapine GAC 73 73 73 NA NA NA 1 3 
Molinate Inert 91 85 97 12 8 16 2 61 
Monochloroacetic Acid GAC 84 39 100 5 5 20 7 57 
Musk Ketone GAC 55 27 83 16 2 30 2 15, 49 
Musk Ketone Inert 10 10 10 2 2 2 1 49 
N,O-didesmethyl-Tramadol Inert 0 -10 10 90 90 90 1 22 
N,O-didesmethyl-
Venlafaxine 
Inert 10 0 20 90 90 90 1 22 
Naproxen GAC 91 9 100 23 2 30 4 
3, 15, 
49, 51 







NDEA Inert 17 0 33 11 7 14 2 16, 27 
N-desmethyl-
Diphenhydramine 
Inert -70 -70 -70 90 90 90 1 22 
N-desmethyl-Tramadol Inert 0 0 0 90 90 90 1 22 
N-desmethyl-Venlafaxine Inert -10 -20 0 90 90 90 1 22 
NDMA Inert 52 3 84 15 7 15 5 
5, 16, 
25, 27 
Nicotine Inert 8 8 8 23 23 23 1 51 
Nicotine GAC 55 55 55 23 23 23 1 51 
NMOR Inert 8 -86 28 11 7 14 3 
5, 16, 
27 
N-Nitrosodi-n-butylamine Inert 14 14 14 7 7 7 1 27 
N-Nitrosopiperidine Inert 20 20 20 7 7 7 1 27 
Nonylphenol GAC 84 84 84 NA NA NA 1 23 
Nonylphenol Inert 53 -25 98 NA NA NA 2 5, 39 
o-chlorophenol Inert 82 69 85 4 4 4 3 36 
Octylphenol GAC 25 25 25 30 30 30 1 15, 28 
O-desmethyl-Naproxen Inert 80 70 90 90 90 90 1 22 
O-desmethyl-Tramadol Inert 0 -10 10 90 90 90 1 22 
O-desmethyl-Venlafaxine Inert 0 -10 10 90 90 90 1 22 
Olfoxacin GAC 9 9 9 NA NA NA 1 3 
Olmesartan Inert 0 -10 10 90 90 90 1 22 
Oxazepam GAC 73 50 96 NA NA NA 1 3 
107 
Oxazepam Inert 4 -15 96 105 90 120 3 
5, 22, 
45 
Oxolinic Acid Inert 0 0 0 20 20 20 1 35 
Oxybenzone GAC 98 98 98 2 2 2 1 49 
Oxybenzone Inert 53 14 73 2 2 2 1 
1, 49, 
52 
Oxypurinol Inert 0 -10 10 90 90 90 1 22 
Paracetamol Inert 90 85 95 120 120 120 1 45 
Paraxanthine Inert 0 0 0 23 23 23 1 51 
Paraxanthine GAC 86 86 86 23 23 23 1 51 
p-Chloro-m-cresol Inert 97 56 98 NA NA NA 1 42 
p-Chloro-m-xylenol Inert 44 18 47 NA NA NA 1 42 
Pentoxifylline GAC 90 90 90 2 2 2 1 49 
Pentoxifylline Inert 13 13 13 2 2 2 1 49 
Perindopril GAC 11 0 22 14 9 18 2 46 
Perindopril Inert 0 0 0 8 8 8 1 44 
Phenol Inert 84 10 99 4 4 15 13 31, 36 
Phenytoin GAC 90 80 95 18 2 30 3 
15, 46, 
49 
Phenytoin Inert 10 0 93 18 2 120 8 




Primidone GAC 83 73 92 27 23 30 1 15, 51 





Progesterone GAC 99 99 99 2 2 2 1 49 
Progesterone Inert 75 52 98 9 2 16 2 8, 49 
Prometon Inert 1 0 3 12 8 16 2 61 
Propachlor Inert 99 99 99 16 16 16 1 8 
Propanolol GAC 17 17 17 NA NA NA 1 18 
Propanolol Inert 94 45 98 NA NA NA 1 9 
Propiconazole Inert 17 0 21 NA NA NA 1 9 
Propranolol Inert 15 0 31 8 8 8 1 39, 44 
p-Toluenesulfonic Acid Inert 87 30 99 12 3 30 18 47 
Ramipril Inert 50 20 80 90 90 90 1 22 
Ramiprilat Inert 50 40 60 90 90 90 1 22 
Ranitidine GAC 39 39 39 NA NA NA 1 3 
Ranitidine Inert 88 48 92 68 16 120 2 8, 45 
Roxithromycin GAC 8 0 15 14 9 18 2 14, 46 
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Roxithromycin Inert 53 25 93 64 8 120 2 44, 45 
Saccharine Inert 100 100 100 90 90 90 1 22 
Salicylic Acid GAC 7 7 7 22 22 22 1 7 
Salicylic Acid Inert 18 10 25 11 11 11 1 7, 5 
Saxitoxin C1 Inert 48 0 95 15 15 15 2 30 
Saxitoxin C2 Inert 95 95 95 15 15 15 1 30 
Saxitoxin GTX2 Inert -360 -360 -360 15 15 15 1 30 
Saxitoxin GTX3 Inert -230 -360 -100 15 15 15 2 30 
Sertraline GAC 89 88 90 14 9 18 2 46 
Simazine GAC 58 29 88 8 7 9 2 33 
Simazine Inert 8 -15 98 14 8 16 4 5, 8, 61 
Sitagliptin Inert 0 0 0 90 90 90 1 22 
Sodium diclofenac Inert 2 -10 6 NA NA NA 1 42 
Sotalol GAC 87 81 93 NA NA NA 1 3 
Sotalol Inert 0 -10 10 90 90 90 1 22 
Sucralose Inert 0 -5 85 18 14 90 4 
8, 16, 
22, 35 
Sulfadiazine GAC 100 100 100 23 23 23 1 51 
Sulfadiazine Inert 0 0 78 17 8 23 3 
35, 44, 
51 
Sulfadimethoxine Inert 68 68 68 23 23 23 1 51 
Sulfadimethoxine GAC 100 100 100 23 23 23 1 51 
Sulfamethazine Inert 0 0 0 20 20 20 1 35 
Sulfamethizole Inert 0 0 0 14 14 14 1 16 




Sulfamethoxazole Inert 27 -42 100 16 2 120 20 








Sulfasalazine GAC 100 100 100 23 23 23 1 51 
Sulfasalazine Inert 9 -82 100 23 23 23 2 5, 51 
Sulfathiazole Inert 85 85 85 23 23 23 1 51 
Sulfathiazole GAC 100 100 100 23 23 23 1 51 
Sulpiride Inert 0 -10 10 90 90 90 1 22 








TCPP GAC 85 20 100 27 23 30 2 15, 51 










14 14 14 1 16 
Tebuconazole Inert 58 0 59 NA NA NA 1 9 
Telmisartan Inert -10 -30 10 90 90 90 1 22 
Temazepam Inert 14 7 97 120 120 120 2 5, 45 
Terbutaline GAC 59 59 59 NA NA NA 1 3 
Terbutryn Inert 0 0 0 90 90 90 1 22 
Terbutylazine Inert 13 13 13 7 7 7 1 27 
Testosterone GAC 96 96 96 2 2 2 1 49 
Testosterone Inert 35 35 35 2 2 2 1 49 
Tetrachloroethylene Inert 9 9 9 6 6 6 1 40 
Tetraglyme Inert 0 -20 20 90 90 90 1 22 
Theobromine Inert 0 0 0 20 20 20 1 35 
Theophylline Inert 0 0 0 21 20 23 1 35, 51 
Theophylline GAC 86 86 86 23 23 23 1 51 
Tolyltriazole GAC 75 75 75 32 32 32 1 32 
Tolyltriazole Inert 0 0 0 29 29 29 1 32 
Tonalide GAC 67 67 67 NA NA NA 1 23 
Tonalide Inert 82 81 83 NA NA NA 1 39 
Torsemide Inert 0 0 0 90 90 90 1 22 
Total Diuron Inert -11 -11 -11 NA NA NA 1 5 
Tramadol GAC 97 76 99 18 9 18 4 
3, 14, 
46 
Tramadol Inert 0 -35 98 90 8 120 4 
5, 22, 
44, 45 
Tramadol-N-oxide GAC 50 50 50 32 32 32 1 32 
Tramadol-N-oxide Inert 40 40 40 29 29 29 1 32 
Tributyl Phosphate Inert 16 10 24 8 6 16 3 40, 61 
Trichloroacetic Acid GAC 82 7 99 15 5 20 18 
14, 57, 
58, 59 
Trichloromethane GAC 5 1 40 2 2 18 5 14, 54 
Trichloromethane Inert 14 5 21 8 4 8 8 53, 54 
Triclocarban GAC 100 100 100 23 23 23 1 51 
Triclocarban Inert 85 73 100 23 23 23 2 1, 51 
Triclopyr GAC 22 9 35 14 9 18 2 46 
Triclopyr Inert 5 5 5 NA NA NA 1 5 
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Triclosan GAC 98 95 100 20 2 30 4 
15, 23, 
49, 51 





Triethyl phosphate Inert 11 11 11 NA NA NA 1 5 
Trimethoprim GAC 97 94 100 20 2 30 4 
3, 15, 
49, 51 








Trinexapac-ethyl Inert 99 99 99 16 16 16 1 8 
Tris(2-chloroethyl) 
phosphate 
Inert 6 -6 19 6 6 6 2 5, 40 
Tris(chloropropyl) phosphate 
isomers 
Inert 0 0 0 NA NA NA 1 5 
Tris(dichloroisopropyl) 
phosphate 
Inert -11 -11 -11 6 6 6 1 40 
Tris(dichloro-propyl) 
phosphate 
Inert -1 -1 -1 NA NA NA 1 5 
Trovafloxacin Mesylate GAC 79 79 79 22 22 22 1 7 
Trovafloxacin Mesylate Inert 15 15 15 11 11 11 1 7 
Valproic Acid Inert 99 97 99 NA NA NA 1 42 
Valsartan Inert 99 25 100 16 8 90 3 
8, 22, 
44 
Valsartan acid Inert -30 -50 -10 90 90 90 1 22 
Venlafaxine GAC 88 68 99 18 9 18 4 
3, 14, 
46 




Warfarin Inert 54 0 99 16 8 20 4 
8, 35, 
61 
β-cyclocitral Inert 45 30 55 3 3 3 4 56 
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Appendix B: TOrC Removals 
Table 16: Average TOrC removals from January-April 2021 
Parameter 







Acetaminophen 90 90 90 
Caffeine 87.72 73.06 83.20 
Ibuprofen 60.87 33.82 73.39 
Naproxen 74.62 56.80 79.09 
Atenolol 27.27 9.95 3.73 
Trimethoprim 62.19 24.05 46.47 
Triclosan 33.80 14.73 61.74 
Gemfibrozil -49.18 -56.18 -51.51 
DEET 10.55 -3.12 3.07 
Meprobamate 2.78 -1.31 4.01 
Sulfamethoxazole -36.79 -17.19 -40.73 
Fluoxetine 56.32 31.21 55.22 
Carbamazepine 9.98 3.07 -3.39 
TCEP -6.48 -12.59 0.04 
Sucralose (x100) -0.78 -3.86 -9.59 
Primidone -9.42 -17.65 -7.85 
Triclocarban - - - 
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Table 17: TOrC removals for May 2021 
Parameter 







Acetaminophen 90 90 90 
Caffeine 0.00 -32.01 19.60 
Ibuprofen 62.26 32.07 72.83 
Naproxen 67.86 64.28 80.00 
Atenolol 28.57 15.14 44.28 
Trimethoprim 36.92 11.38 -10.77 
Triclosan -11.27 -13.24 18.87 
Gemfibrozil -80.00 -120.81 -144.81 
DEET 22.00 6.40 16.00 
Meprobamate 0.00 1.17 15.29 
Sulfamethoxazole -47.06 -32.36 -48.24 
Fluoxetine 35.29 40.00 65.06 
Carbamazepine 0.00 4.00 10.00 
TCEP 8.00 13.60 28.00 
Sucralose (x100) -5.71 -9.72 0.57 
Primidone -11.76 -5.89 15.29 
Triclocarban - - - 
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Appendix C: qPCR Data 
Table 18: 16S rRNA concentrations  
Date Location Type 




1/26/2021 Sec Eff Effluent 1.28E+10 4.39E+09 
2/23/2021 Sec Eff Effluent 1.09E+10 4.59E+09 
3/23/2021 Sec Eff Effluent 1.67E+10 3.24E+08 
4/20/2021 Sec Eff Effluent 1.37E+10 3.80E+08 
1/26/2021 Control BAF Effluent 3.61E+08 3.13E+07 
2/23/2021 Control BAF Effluent 3.18E+08 2.03E+07 
3/23/2021 Control BAF Effluent 3.36E+08 1.60E+07 
4/20/2021 Control BAF Effluent 3.39E+08 4.29E+07 
1/26/2021 Ammonia BAF Effluent 3.55E+08 1.23E+07 
2/23/2021 Ammonia BAF Effluent 4.26E+08 1.10E+07 
3/23/2021 Ammonia BAF Effluent 5.11E+08 1.22E+07 
4/20/2021 Ammonia BAF Effluent 4.91E+08 6.33E+07 
1/26/2021 Chloramine BAF Effluent 4.09E+08 1.43E+06 
2/23/2021 Chloramine BAF Effluent 1.92E+08 5.60E+05 
3/23/2021 Chloramine BAF Effluent 4.30E+08 3.32E+06 
4/20/2021 Chloramine BAF Effluent 4.67E+08 1.26E+07 
2/23/2021 Neg Ctrl 1 Effluent 2.51E+03 5.13E+02 
4/20/2021 Neg con 2 Effluent 2.51E+03 1.18E+02 
1/26/2021 Chloramine BAF Filter 3.50E+08 2.26E+07 
2/23/2021 Chloramine BAF Filter 1.18E+08 7.63E+06 
3/23/2021 Chloramine BAF Filter 1.60E+08 3.23E+06 
4/20/2021 Chloramine BAF Filter 2.80E+08 4.63E+06 
1/26/2021 Ammonia BAF Filter 2.51E+08 1.31E+07 
2/23/2021 Ammonia BAF Filter 7.65E+08 3.28E+07 
3/23/2021 Ammonia BAF Filter 6.10E+08 8.83E+06 
4/20/2021 Ammonia BAF Filter 3.72E+08 1.47E+07 
1/26/2021 Control BAF Filter 1.40E+08 4.09E+06 
2/23/2021 Control BAF Filter 3.16E+08 4.33E+06 
3/23/2021 Control BAF Filter 3.42E+08 5.96E+06 
4/20/2021 Control BAF Filter 1.86E+08 7.11E+06 
1/26/2021 negative control 1 Filter 3.69E+01 9.17E-01 
2/23/2021 negative control 2 Filter 3.54E+01 4.11E+00 
3/23/2021 negative control 3 Filter 3.39E+01 4.87E+00 
4/20/2021 negative control 4 Filter 3.72E+01 3.80E+00 
1/26/2021 Negative control 2 Media 3.04E+01 4.93E+00 
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2/23/2021 negative control 3 Media 2.85E+01 1.87E+00 
3/23/2021 negative control 4 Media 5.87E+01 1.89E+01 
4/20/2021 negative control 6 Media 4.93E+01 1.35E+01 
4/20/2021 negative control 7 Media 3.78E+01 4.18E+00 
5/18/2021 negative control 8 Media 2.86E+01 2.03E+00 
1/26/2021 Chloramine BAF - Bottom Media 2.00E+09 4.63E+07 
2/23/2021 Chloramine BAF - Bottom Media 1.22E+09 6.64E+07 
3/23/2021 Chloramine BAF - Bottom Media 2.77E+08 7.04E+06 
4/20/2021 Chloramine BAF - Bottom Media 5.23E+08 6.23E+07 
5/18/2021 Chloramine BAF - Bottom Media 1.87E+09 1.11E+08 
1/26/2021 Chloramine BAF - Top Media 5.97E+08 1.44E+07 
2/23/2021 Chloramine BAF - Top Media 7.34E+08 2.73E+07 
3/23/2021 Chloramine BAF - Top Media 1.51E+07 1.18E+06 
4/20/2021 Chloramine BAF - Top Media 2.50E+08 1.66E+07 
5/18/2021 Chloramine BAF - Top Media 1.02E+09 1.26E+07 
1/26/2021 Ammonia BAF - Bottom Media 8.60E+08 6.80E+06 
2/23/2021 Ammonia BAF - Bottom Media 6.78E+08 6.34E+07 
3/23/2021 Ammonia BAF - Bottom Media 5.02E+08 7.17E+07 
4/20/2021 Ammonia BAF - Bottom Media 3.54E+08 5.00E+06 
5/18/2021 Ammonia BAF - Bottom Media 1.12E+09 1.27E+08 
1/26/2021 Ammonia BAF - Top Media 2.81E+08 1.75E+07 
2/23/2021 Ammonia BAF - Top Media 3.31E+08 9.46E+05 
3/23/2021 Ammonia BAF - Top Media 2.83E+08 5.75E+07 
4/20/2021 Ammonia BAF - Top Media 9.55E+08 2.37E+07 
5/18/2021 Ammonia BAF - Top Media 1.20E+09 4.81E+07 
1/26/2021 Control BAF - Bottom Media 1.32E+09 2.19E+07 
2/23/2021 Control BAF - Bottom Media 9.25E+08 1.11E+08 
3/23/2021 Control BAF - Bottom Media 2.79E+08 1.04E+07 
4/20/2021 Control BAF - Bottom Media 1.87E+08 9.07E+06 
5/18/2021 Control BAF - Bottom Media 2.74E+10 2.63E+09 
1/26/2021 Control BAF - Top Media 1.44E+09 9.64E+06 
2/23/2021 Control BAF - Top Media 1.63E+09 2.02E+08 
3/23/2021 Control BAF - Top Media 3.25E+08 1.53E+07 
4/20/2021 Control BAF - Top Media 3.53E+08 1.14E+07 
5/18/2021 Control BAF - Top Media 2.44E+09 8.90E+07 
116 
Table 19: AOA concentrations 
Date Location Type 




1/26/2021 Sec Eff Effluent 6.21E+04 7.52E+03 
2/23/2021 Sec Eff Effluent 1.11E+05 3.43E+03 
3/23/2021 Sec Eff Effluent 5.49E+03 2.90E+03 
4/20/2021 Sec Eff Effluent 3.56E+04 1.55E+02 
1/26/2021 Control BAF Effluent <LOQ <LOQ 
2/23/2021 Control BAF Effluent <LOQ <LOQ 
3/23/2021 Control BAF Effluent 3.85E+06 4.36E+05 
4/20/2021 Control BAF Effluent <LOQ <LOQ 
1/26/2021 Ammonia BAF Effluent <LOQ <LOQ 
2/23/2021 Ammonia BAF Effluent 4.33E+06 2.96E+05 
3/23/2021 Ammonia BAF Effluent 9.38E+06 3.90E+05 
4/20/2021 Ammonia BAF Effluent 5.12E+06 6.52E+05 
1/26/2021 Chloramine BAF Effluent <LOQ <LOQ 
2/23/2021 Chloramine BAF Effluent <LOQ <LOQ 
3/23/2021 Chloramine BAF Effluent 1.14E+07 1.66E+06 
4/20/2021 Chloramine BAF Effluent 4.18E+06 2.62E+05 
2/23/2021 Neg Ctrl 1 Effluent <LOQ <LOQ 
4/20/2021 Neg con 2 Effluent <LOQ <LOQ 
1/26/2021 Chloramine BAF Filter 5.53E+04 5.13E+03 
2/23/2021 Chloramine BAF Filter <LOQ <LOQ 
3/23/2021 Chloramine BAF Filter <LOQ <LOQ 
4/20/2021 Chloramine BAF Filter 5.42E+04 1.12E+04 
1/26/2021 Ammonia BAF Filter 6.64E+04 1.49E+03 
2/23/2021 Ammonia BAF Filter 1.03E+05 3.32E+03 
3/23/2021 Ammonia BAF Filter 5.96E+04 1.38E+03 
4/20/2021 Ammonia BAF Filter <LOQ <LOQ 
1/26/2021 Control BAF Filter 5.13E+04 7.11E+03 
2/23/2021 Control BAF Filter 6.85E+04 9.90E+03 
3/23/2021 Control BAF Filter <LOQ <LOQ 
4/20/2021 Control BAF Filter <LOQ <LOQ 
1/26/2021 negative control 1 Filter <LOQ <LOQ 
2/23/2021 negative control 2 Filter <LOQ <LOQ 
3/23/2021 negative control 3 Filter <LOQ <LOQ 
4/20/2021 negative control 4 Filter <LOQ <LOQ 
1/26/2021 Negative control 2 Media <LOQ <LOQ 
2/23/2021 negative control 3 Media <LOQ <LOQ 
3/23/2021 negative control 4 Media <LOQ <LOQ 
4/20/2021 negative control 6 Media <LOQ <LOQ 
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4/20/2021 negative control 7 Media <LOQ <LOQ 
5/18/2021 negative control 8 Media <LOQ <LOQ 
1/26/2021 Chloramine BAF - Bottom Media 1.33E+06 1.36E+05 
2/23/2021 Chloramine BAF - Bottom Media 6.82E+05 1.31E+05 
3/23/2021 Chloramine BAF - Bottom Media 3.80E+05 6.83E+04 
4/20/2021 Chloramine BAF - Bottom Media <LOQ <LOQ 
5/18/2021 Chloramine BAF - Bottom Media 1.28E+06 1.11E+05 
1/26/2021 Chloramine BAF - Top Media <LOQ <LOQ 
2/23/2021 Chloramine BAF - Top Media 8.04E+05 9.68E+04 
3/23/2021 Chloramine BAF - Top Media <LOQ <LOQ 
4/20/2021 Chloramine BAF - Top Media 2.22E+05 6.49E+03 
5/18/2021 Chloramine BAF - Top Media <LOQ <LOQ 
1/26/2021 Ammonia BAF - Bottom Media 4.84E+05 1.44E+04 
2/23/2021 Ammonia BAF - Bottom Media 1.13E+06 1.44E+05 
3/23/2021 Ammonia BAF - Bottom Media <LOQ <LOQ 
4/20/2021 Ammonia BAF - Bottom Media <LOQ <LOQ 
5/18/2021 Ammonia BAF - Bottom Media 1.76E+06 2.22E+05 
1/26/2021 Ammonia BAF - Top Media 2.41E+05 2.92E+04 
2/23/2021 Ammonia BAF - Top Media 4.35E+05 1.62E+04 
3/23/2021 Ammonia BAF - Top Media <LOQ <LOQ 
4/20/2021 Ammonia BAF - Top Media 7.43E+05 4.53E+04 
5/18/2021 Ammonia BAF - Top Media 3.55E+05 3.70E+03 
1/26/2021 Control BAF - Bottom Media 1.12E+06 6.72E+04 
2/23/2021 Control BAF - Bottom Media 1.90E+06 7.78E+04 
3/23/2021 Control BAF - Bottom Media <LOQ <LOQ 
4/20/2021 Control BAF - Bottom Media <LOQ <LOQ 
5/18/2021 Control BAF - Bottom Media 2.46E+06 2.08E+05 
1/26/2021 Control BAF - Top Media 7.70E+05 2.50E+05 
2/23/2021 Control BAF - Top Media 2.48E+06 1.07E+05 
3/23/2021 Control BAF - Top Media 2.69E+05 4.98E+04 
4/20/2021 Control BAF - Top Media 3.37E+05 1.29E+03 
5/18/2021 Control BAF - Top Media 1.06E+06 1.51E+05 
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Table 20: AOB concentrations 
Date Location Type 




1/26/2021 Sec Eff Effluent 1.07E+05 1.69E+03 
2/23/2021 Sec Eff Effluent 1.28E+05 7.39E+03 
3/23/2021 Sec Eff Effluent 2.72E+05 5.78E+03 
4/20/2021 Sec Eff Effluent 5.61E+05 1.12E+04 
1/26/2021 Control BAF Effluent <LOQ <LOQ 
2/23/2021 Control BAF Effluent <LOQ <LOQ 
3/23/2021 Control BAF Effluent <LOQ <LOQ 
4/20/2021 Control BAF Effluent <LOQ <LOQ 
1/26/2021 Ammonia BAF Effluent <LOQ <LOQ 
2/23/2021 Ammonia BAF Effluent <LOQ <LOQ 
3/23/2021 Ammonia BAF Effluent <LOQ <LOQ 
4/20/2021 Ammonia BAF Effluent <LOQ <LOQ 
1/26/2021 Chloramine BAF Effluent <LOQ <LOQ 
2/23/2021 Chloramine BAF Effluent <LOQ <LOQ 
3/23/2021 Chloramine BAF Effluent <LOQ <LOQ 
4/20/2021 Chloramine BAF Effluent <LOQ <LOQ 
2/23/2021 Neg Ctrl 1 Effluent <LOQ <LOQ 
4/20/2021 Neg con 2 Effluent <LOQ <LOQ 
1/26/2021 Chloramine BAF Filter 2.94E+05 5.45E+04 
2/23/2021 Chloramine BAF Filter 1.92E+05 1.26E+04 
3/23/2021 Chloramine BAF Filter 5.87E+05 3.26E+04 
4/20/2021 Chloramine BAF Filter 2.96E+05 5.08E+04 
1/26/2021 Ammonia BAF Filter 1.00E+06 2.03E+04 
2/23/2021 Ammonia BAF Filter 2.83E+06 1.21E+05 
3/23/2021 Ammonia BAF Filter 5.30E+06 2.01E+05 
4/20/2021 Ammonia BAF Filter 6.57E+05 1.76E+04 
1/26/2021 Control BAF Filter 2.49E+05 1.04E+04 
2/23/2021 Control BAF Filter 3.57E+05 3.77E+04 
3/23/2021 Control BAF Filter 1.34E+06 1.04E+05 
4/20/2021 Control BAF Filter 4.23E+05 5.59E+04 
1/26/2021 negative control 1 Filter <LOQ <LOQ 
2/23/2021 negative control 2 Filter <LOQ <LOQ 
3/23/2021 negative control 3 Filter <LOQ <LOQ 
4/20/2021 negative control 4 Filter <LOQ <LOQ 
1/26/2021 Negative control 2 Media <LOQ <LOQ 
2/23/2021 negative control 3 Media <LOQ <LOQ 
3/23/2021 negative control 4 Media <LOQ <LOQ 
4/20/2021 negative control 6 Media <LOQ <LOQ 
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4/20/2021 negative control 7 Media <LOQ <LOQ 
5/18/2021 negative control 8 Media <LOQ <LOQ 
1/26/2021 Chloramine BAF - Bottom Media 1.18E+07 1.47E+05 
2/23/2021 Chloramine BAF - Bottom Media 5.06E+06 2.89E+05 
3/23/2021 Chloramine BAF - Bottom Media 9.05E+05 1.96E+04 
4/20/2021 Chloramine BAF - Bottom Media 1.24E+06 1.25E+05 
5/18/2021 Chloramine BAF - Bottom Media 7.06E+06 5.73E+05 
1/26/2021 Chloramine BAF - Top Media 9.01E+06 1.34E+05 
2/23/2021 Chloramine BAF - Top Media 5.36E+06 5.58E+04 
3/23/2021 Chloramine BAF - Top Media <LOQ <LOQ 
4/20/2021 Chloramine BAF - Top Media 2.64E+06 1.22E+06 
5/18/2021 Chloramine BAF - Top Media 4.84E+06 2.61E+05 
1/26/2021 Ammonia BAF - Bottom Media 6.01E+06 3.89E+05 
2/23/2021 Ammonia BAF - Bottom Media 4.97E+06 5.39E+05 
3/23/2021 Ammonia BAF - Bottom Media 1.64E+06 2.38E+05 
4/20/2021 Ammonia BAF - Bottom Media 1.38E+06 3.04E+05 
5/18/2021 Ammonia BAF - Bottom Media 5.33E+06 4.22E+05 
1/26/2021 Ammonia BAF - Top Media 4.85E+06 3.57E+05 
2/23/2021 Ammonia BAF - Top Media 5.34E+06 1.00E+05 
3/23/2021 Ammonia BAF - Top Media 4.86E+06 1.27E+05 
4/20/2021 Ammonia BAF - Top Media 1.21E+07 4.38E+05 
5/18/2021 Ammonia BAF - Top Media 2.29E+07 1.94E+06 
1/26/2021 Control BAF - Bottom Media 6.60E+06 2.04E+05 
2/23/2021 Control BAF - Bottom Media 3.65E+06 1.54E+05 
3/23/2021 Control BAF - Bottom Media 2.28E+06 1.25E+05 
4/20/2021 Control BAF - Bottom Media 4.20E+05 1.98E+04 
5/18/2021 Control BAF - Bottom Media 6.59E+06 1.18E+05 
1/26/2021 Control BAF - Top Media 9.17E+06 7.25E+05 
2/23/2021 Control BAF - Top Media 5.74E+06 4.36E+05 
3/23/2021 Control BAF - Top Media 1.26E+06 6.67E+04 
4/20/2021 Control BAF - Top Media 1.79E+06 7.09E+04 
5/18/2021 Control BAF - Top Media 4.99E+06 5.31E+05 
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Table 21: Comammox concentrations 
Date Location Type 




1/26/2021 Sec Eff Effluent 4.11E+05 2.21E+04 
2/23/2021 Sec Eff Effluent 3.96E+05 5.06E+03 
3/23/2021 Sec Eff Effluent 1.87E+05 1.57E+04 
4/20/2021 Sec Eff Effluent 4.92E+05 4.65E+04 
1/26/2021 Control BAF Effluent 1.97E+06 9.99E+04 
2/23/2021 Control BAF Effluent 1.84E+06 8.50E+04 
3/23/2021 Control BAF Effluent 2.48E+06 3.18E+05 
4/20/2021 Control BAF Effluent 1.83E+06 1.17E+05 
1/26/2021 Ammonia BAF Effluent 2.05E+06 1.89E+05 
2/23/2021 Ammonia BAF Effluent 3.60E+06 5.45E+05 
3/23/2021 Ammonia BAF Effluent 3.71E+06 7.81E+05 
4/20/2021 Ammonia BAF Effluent 2.92E+06 3.36E+05 
1/26/2021 Chloramine BAF Effluent <LOQ <LOQ 
2/23/2021 Chloramine BAF Effluent <LOQ <LOQ 
3/23/2021 Chloramine BAF Effluent 5.03E+06 6.30E+05 
4/20/2021 Chloramine BAF Effluent 3.72E+06 3.17E+05 
2/23/2021 Neg Ctrl 1 Effluent <LOQ <LOQ 
4/20/2021 Neg con 2 Effluent <LOQ <LOQ 
1/26/2021 Chloramine BAF Filter 7.60E+05 2.06E+04 
2/23/2021 Chloramine BAF Filter 7.04E+05 4.61E+04 
3/23/2021 Chloramine BAF Filter 1.23E+06 9.01E+04 
4/20/2021 Chloramine BAF Filter 4.42E+05 1.62E+04 
1/26/2021 Ammonia BAF Filter 4.76E+05 5.06E+03 
2/23/2021 Ammonia BAF Filter 1.73E+06 3.52E+04 
3/23/2021 Ammonia BAF Filter 9.08E+05 1.13E+05 
4/20/2021 Ammonia BAF Filter 6.01E+05 3.87E+04 
1/26/2021 Control BAF Filter 3.89E+05 1.34E+04 
2/23/2021 Control BAF Filter 1.31E+06 6.85E+04 
3/23/2021 Control BAF Filter 1.35E+06 9.31E+04 
4/20/2021 Control BAF Filter 5.43E+05 3.93E+04 
1/26/2021 negative control 1 Filter <LOQ <LOQ 
2/23/2021 negative control 2 Filter <LOQ <LOQ 
3/23/2021 negative control 3 Filter <LOQ <LOQ 
4/20/2021 negative control 4 Filter <LOQ <LOQ 
1/26/2021 Negative control 2 Media <LOQ <LOQ 
2/23/2021 negative control 3 Media <LOQ <LOQ 
3/23/2021 negative control 4 Media <LOQ <LOQ 
4/20/2021 negative control 6 Media <LOQ <LOQ 
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4/20/2021 negative control 7 Media <LOQ <LOQ 
5/18/2021 negative control 8 Media <LOQ <LOQ 
1/26/2021 Chloramine BAF - Bottom Media 8.88E+06 3.11E+05 
2/23/2021 Chloramine BAF - Bottom Media 2.82E+07 2.87E+06 
3/23/2021 Chloramine BAF - Bottom Media 9.10E+05 1.10E+05 
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